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Abstract 
 
Inhibition of protein-protein interactions is a promising therapeutic strategy for 
targeting non-enzymatic proteins.  One strategy to inhibit protein-protein interactions is 
to design inhibitors specifically toward the protein-protein interaction interface.  To 
achieve this objective using structure-aided design, knowledge of the structure of the 
interface of the protein-protein interaction is needed.  Augmenting the utility of NMR to 
determine the structure of larger proteins, and of protein complexes, than is currently 
achieved with conventional approaches, expands structure-aided design and to 
evaluate protein-protein interactions for target proteins relevant to human disease such 
as cancer.  A second approach to bring new therapies to the clinic is to identify lead 
molecules using high-throughput screening.  High-throughput screening (HTS) offers 
the potential to more rapidly and less expensively identify promising molecules that may 
inhibit a specific protein-protein interaction. 
To improve efforts at structure-aided design, we hypothesize that we can expand 
the utility of fluorescence- and NMR-based approaches to monitor protein-protein 
interactions by incorporating fluorescent or paramagnetic labels, site-specifically, into a 
protein of interest.  This technology will provide much more structural detail regarding 
the binding site of a candidate small molecule protein-protein interaction inhibitor.  This 
structural information can then be used in downstream medicinal chemistry efforts to 
improve inhibitor affinity and specificity.  Additionally, site-specific fluorescent and 
paramagnetic labels can be used in sensitive HTS assays for protein-protein interaction 
inhibitors. 
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The lanthanide series of elements, which possess intriguing spectroscopic and 
paramagnetic properties, was chosen to accomplish these efforts.  Lanthanides exhibit 
luminescence and have excitation and emission maxima unique from biological 
fluorophores, broad Stokes shifts, and narrow emission bands.  In the context of NMR, 
some lanthanides impart long-range perturbations in the form of paramagnetic 
relaxation enhancements, pseudocontact chemical shifts, and residual dipolar 
couplings, which are used to facilitate protein structure determination. Site-specific 
labeling of the protein of interest was achieved using site-directed mutagenesis, 
incorporation of the unnatural amino acid paF, followed by copper-free click chemistry 
with a cyclooctyne-containing lanthanide chelator.  Synthesis of the small-molecule 
lanthanide chelator amenable to copper-free click chemistry-mediated incorporation is 
described herein.   
To improve efforts at identification of candidate protein-protein interaction 
inhibitors, we hypothesized that a high-throughput fluorescence polarization screening 
assay could be established.  Inhibitors identified in this assay would be further 
characterized using the lanthanide labeled Survivin protein.  A recently-identified cancer 
target, the Survivin protein, was evaluated using the methodologies described herein. 
The results demonstrate we were able to fluorescently label the Survivin protein site-
specifically using a click chemistry approach.  In addition, preliminary fluorescence 
results indicate that synthesis of a clickable lanthanide chelator was also successful.   
Finally, a high-throughput fluorescence polarization-based screening platform for 
analyzing Survivin protein-peptide interactions was evaluated.   
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Taken together, the methodologies described herein attempt to augment efforts 
at structure-aided drug design as well as to produce new technologies to identify 
promising protein-protein interaction inhibitors, with the ultimate goal of improving our 
understanding of protein-protein interactions implicated in many human diseases, 
including cancer. 
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Chapter 1. Introduction 
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1.1 Incidence of Cancer 
According to the American Cancer Society, more than 1.6 million new cases of 
cancer will be diagnosed in 2015 in the United States [American Cancer Society, 2015]. 
Of these, more than 589,000 are expected to be fatal, which corresponds to 1620 
people per day.  Nearly 1 in 4 deaths in the U.S. is from cancer with heart disease being 
the only cause of death more prevalent.  In 2009, the National Institutes of Health (NIH) 
reported that the annual healthcare burden was more than $216 billion from all cancers 
[American Cancer Society, 2015].  Finally, although for most cancers, the one- and five-
year survival rates are increasing, some cancers remain exceedingly difficult to treat, 
and exhibit very high mortality rates [American Cancer Society, 2015].  These 
staggering statistics indicate that in spite of decades of efforts and many breakthroughs, 
the need for additional anti-cancer therapies is still pressing.  A protein that is being 
pursued for anti-cancer therapy is Survivin [Ambrosini, et al., 1997, reviewed in Altieri, 
2008, Condon, 2011]. 
  
1.2 Survivin 
 1.2.1 Survivin Prevents Apoptosis 
Survivin is a 142-amino acid, 16.5 kDa protein expressed predominately in fetal 
tissues; it is undetectable in terminally-differentiated adult tissues [Ambrosini, et al., 
1997, Reed, 2001, Salvesen and Duckett, 2002, Sah, et al. 2006] except during mitosis 
[Giodini, et al., 2002].  In vivo, it is normally found as a homodimer with each monomer 
consisting of both a globular and a single long α-helical domain [Chantalat, et al., 2000, 
Muchmore, et al., 2000, Verdecia, et al., 2000, Jeyaprakash, et al., 2007].  Survivin is 
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unusual in that it participates in multiple protein-protein interactions in the cell that are 
critical to survival and proliferation, while being spatially and temporally distinct.  These 
qualities have made it an attractive drug target. 
Initially characterized as a member of the inhibitor of apoptosis protein (IAP) 
family [Ambrosini, et al., 1997], Survivin is thought to prevent apoptosis by binding 
caspases, such as caspase-9 [Deveraux, et al., 1998, Chai, et al., 2000, Du, et al., 
2000, Liu, et al., 2000, Wu, et al., 2000].  When the cell receives a pro-apoptotic signal, 
second mitochondria-activator of caspases/direct IAP binding protein with low pI 
(Smac/DIABLO) is released from the mitochondria [Du, et al., 2000; Verhagen, et al., 
2000, Adrain, et al., 2001].  Through an incompletely-characterized series of events, 
Smac/DIABLO competes with caspases for Survivin binding [Sun, et al., 2005, Condon, 
2011] at Survivin’s baculoviral inhibitor of apoptosis repeat (BIR) domain, which is 
comprised of amino acids 11 to 80.  Survivin sequestration by Smac/DIABLO releases 
the activator caspases to elicit apoptosis.   
 
1.2.2 Survivin Is Required for Mitosis 
Although initially characterized as an IAP, Survivin also binds tubulin and 
stabilizes growing microtubules [Li, et al., 1998, Giodini, et al., 2002].  Additionally, 
Survivin is imperative for chromosomal segregation [Skoufias, et al., 2000, Uren, et al., 
2000, Jiang, et al., 2001, Wheatley, et al., 2001].  Within the dividing cell, the proteins 
aurora B, borealin, inner centromere protein (INCENP), and Survivin congregate at the 
centromere of the chromosome to facilitate proper segregation, ensuring that each 
daughter cell receives the correct number of chromosomes.  The structure of Survivin 
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within this complex, the chromosomal passenger complex (CPC), has been solved by x-
ray crystallography [Jeyaprakash, et al., 2007, Niedzialkowska, et al., 2012].  Recent 
evidence suggests that the CPC is assembled within the cytosol and then transported 
into the nucleus via the nuclear pore complex [Zhang and Wang, 2012].  Finally, a 
contemporary report described the interaction between histone-3 and the BIR domain of 
Survivin [Jeyaprakash, et al., 2011, Niedzialkowska, et al., 2012], demonstrating that 
this region binds the nucleosome and facilitates proper chromosomal segregation 
during division.  Thus, the number and variety of Survivin protein-protein interactions 
represent many possibilities for therapeutic intervention. 
 
1.2.3 Obstacles to Effective Survivin Inhibition 
Survivin is upregulated more than 40 fold over healthy tissue in numerous types 
of cancers [Ambrosini, et al., 1997, Altieri and Marchisio, 1999, Velculescu, et al., 1999].   
Consequently, Survivin was identified as a new cancer drug target as early as 1997 
[Ambrosini, et al., 1997, reviewed in Altieri, 2008, Condon, 2011] and strategies for 
Survivin inhibition have included peptide vaccines, an antisense oligonucleotide, Smac 
mimetics, small-molecule transcriptional repressors, and protein-protein interaction 
inhibitors [Nakahara, et al., 2007, reviewed in Groner and Weiss, 2014].  Current 
strategies, however, lack efficacy, giving rise to only moderate outcomes [Giaccone, et 
al., 2009, reviewed in Groner and Weiss, 2014] and generate different outcomes 
especially when used in conjunction with other therapies [Carvalho, et al., 2003, 
Cheung, et al., 2009, reviewed in Groner and Weiss, 2014].   
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One challenge to inhibiting Survivin function is that it is non-enzymatic; as a 
consequence, traditional strategies of enzyme inhibition do not apply.  In addition, 
because it lacks a traditional hydrophobic pocket amenable to small-molecule binding, 
Survivin is considered to be “non-druggable“ [reviewed in Groner and Weiss, 2014].  
One strategy to overcome these obstacles is to target Survivin‘s protein-protein 
interactions, a strategy that is gaining ground in the treatment of many diseases 
including cancer [Oikawa, et al., 2010], human papilloma virus infection, and hepatitis C 
virus infection [Zhu, et al., 2010, D’Abramo and Archambault, 2011, Kota, et al., 2012].  
To evaluate the consequences of protein partner binding on the protein of 
interest, fluorescence-based approaches may be utilized.  One advantage of 
fluorescence-based analyses relative to x-ray crystallography and NMR spectroscopy is 
that fluorescence-based approaches tend to be more sensitive, thereby requiring lower 
protein concentrations.  To study proteins that have a tendency to aggregate at high 
concentration and/or where over-expression of the protein in high yield is difficult, the 
improved sensitivity of fluorescence-based analyses is appealing. 
 
1.3 Strategies to Identify or Develop Potential Survivin Protein-Protein Interaction 
Inhibitors 
1.3.1 High-Throughput Chemical Compound Screening to Identify Potential 
Protein-Protein Interaction Inhibitors 
High throughput screening (HTS) of hundreds to thousands of chemical 
compounds against a target protein or protein-protein interaction is gaining appeal for its 
efficiency and reduced costs compared to traditional methods [reviewed in Lea and 
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Simeonov, 2011].  These platforms are advantageous for non-enzymatic protein targets 
where direct analysis of protein function is difficult [Liu, et al., 2000, Glover, et al., 2003, 
Nikolovska-Coleska, et al., 2004, Nikolovska-Coleska, et al., 2008].  While enzymatic 
assays can quantify metabolite production or reactant consumption, proteins that are 
not enzymes are not amenable to these types of “direct” quantifications.  Alternative 
measures of protein function, such as caspase activity assays, may be utilized for 
evaluating the activity of certain proteins involved in apoptosis [Hristov, et al., 2014], 
however, for proteins that are involved in multiple intracellular pathways, ascertaining 
the consequences of disrupting that protein’s function may be inconclusive, i.e., Survivin 
function in apoptosis, but not mitosis, may be altered.  These approaches may require 
numerous components [reviewed Lea and Simeonov, 2011], making the experimental 
setup cumbersome and unwieldy.  Finally, as increasing interest has developed in 
targeting and disrupting protein-protein interactions [Arkin, et al., 2004, Oikawa, et al., 
2010, Zhu, et al., 2010, D’Abramo and Archambault, 2011, Kota, et al., 2012], 
alternative strategies have been sought to evaluate the consequences of disrupting 
target protein function in order to identify inhibitors of protein-protein interactions 
[reviewed in Lea and Simeonov, 2011].  One high-throughput screening platform to 
identify protein-protein interaction inhibitors is fluorescence polarization [reviewed in Lea 
and Simeonov, 2011]. 
 
  Fluorescence Polarization-based High-Throughput Screening 
Fluorescence anisotropy refers to the extent to which a fluorophore is able 
to freely tumble in the analyzed system [Perrin, 1926].  Fluorescence polarization, P, is 
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defined as the ratio of the linearly polarized component’s intensity divided by the natural 
light intensity [Lakowicz, 1999]. Anisotropy, r, is a similar ratio, however, it incorporates 
the total light component’s intensity [Lakowicz, 1999]. 
Briefly, the concept of fluorescence polarization-based HTS, as applied to 
Survivin as a target, is as follows [reviewed in Lea and Simeonov, 2011]: a small (~<20-
mer) synthetic peptide is fluorescently labeled and added to a solution containing 
Survivin.  When the fluorescently-labeled peptide is freely tumbling in solution, i.e. 
unbound, the resulting fluorescence anisotropy or polarization signal is near zero 
because the ratio of the parallel and perpendicular fluorescence intensities is averaged 
out.  As an increasing proportion of the fluorescently-labeled peptide binds Survivin 
protein, the fluorescence anisotropy begins to increase because the rate of fluorophore 
tumbling slows and thus imparts an average fluorescence polarization that can be 
measured.  When all available fluorescently-labeled peptide is bound to the target 
protein Survivin, the fluorescence anisotropy signal becomes saturated (100%) because 
the fluorophore tumbling is at its slowest rate and the largest ratio of vertically to 
horizontally polarized fluorescence intensity is achieved.  A relatively small (<~20-amino 
acids) peptide is used because if the peptide is too large, then it imparts its own 
fluorescence polarization even when unbound to a binding partner. 
To identify candidate inhibitors of a specific protein-protein interaction, 
protein and fluorescently-labeled peptide are combined at fixed concentrations, then 
fluorescence anisotropy or polarization is measured.  Small molecule inhibitors will 
disrupt the protein:peptide binding interaction, eliciting a decrease in the observed 
fluorescence anisotropy or polarization signal as fluorescently-labeled peptide is 
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displaced and freely tumbles.  Promising small molecule candidate inibitors that elicit 
decreased fluorescence anisotropy or polarization are then screened for 
autofluorescence and quenching [Gribbon and Sewing, 2003], two factors that may alter 
the fluorescence polarization or anisotropy signal independent of disruption of the 
protein-protein interaction. 
   
1.3.2 Structure-Aided Inhibitor Design 
Once a lead candidate has been identified from a HTS assay, structure-aided 
drug design can be employed to improve the compound’s affinity and specificity for its 
target [reviewed in Madsen, et al., 2002].  This strategy relies on structural information 
of the 1) target protein small molecule binding pocket or 2) site of a target protein-
protein interaction.  NMR spectroscopy and x-ray crystallography are well-validated 
approaches that yield bond distance and atomic arrangements, which are used to 
determine a protein’s structure in dynamic or static conformations, respectively 
[Wüthrich, 1990, Branden and Tooze, 1998, Wang, et al., 2000, Jorgensen, 2004, 
Schneider and Fechner, 2005].  If the bond distances and atomic arrangements of the 
protein of interest are known, small molecules may be engineered to precisely, and with 
high affinity, bind a therapeutically-relevant pocket of a target protein [He, et al., 2005, 
reviewed in Madsen, et al., 2002], when the target protein contains such a pocket.  As a 
consequence, the high-resolution 3-dimensional structure of the protein facilitates 
structure-aided design of molecules to the specific protein target, an example of which 
is AMN107, an imatinib analog that was designed to overcome imatinib resistance 
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based on point mutations in the tyrosine kinase implicated in chronic myelogenous 
leukemia [Weisberg, et al., 2005].  
1.4 Limitations of Protein Structure Determination Methods 
 Although it is sometimes possible to obtain very high resolution structural 
information, one limitation of x-ray crystallography is that the resulting image represents 
the crystal structure rather than the solution structure.  In comparison, efforts are 
ongoing to expand the utility of NMR spectroscopy to study protein dynamics, protein-
protein interactions, and to resolve “lowly-populated states” [Iwahara and Clore, 2006], 
states not easily observed using conventional NMR spectroscopy approaches.  
Understanding conformational dynamics is important to drug development because 
many times the lowly-populated conformational substates are relevant to a desired 
pharmacological effect [Lampe, et al., 2010]. 
 
1.5 Utility of Lanthanides in Structural Biology 
Lanthanides are a series of rare earth metals, most of which carry a +3 charge.  
Lanthanides have recently found utility in structural biology applications, such as 
analyzing protein dynamics, because of their unique spectroscopic [Nitz, et al., 2004] 
and paramagnetic properties, which can be utilized in fluorescence-based approaches 
and NMR [Su, et al., 2006, Otting, 2008, Allen and Imperiali, 2010, Su and Otting, 
2010]. 
 
1.5.1 Lanthanide Fluorescence and Biological Utility 
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Lanthanides exhibit fluorescent properties when the lanthanide ion is chelated in 
a specific chemical microenvironment.  When a chelating group binds and interacts with 
most of the lanthanide’s nine possible coordination sites, the lanthanide is also shielded 
from any solvent quenching effects that may reduce luminescence [Pietraszkiewicz, et 
al., 1993].  Lanthanides are relatively insensitive to photobleaching [Pandya, 2006] and 
have broad Stokes shifts and narrow emission bands [Murphy and Barton, 1993].  
Excitation promotes an electron to the triplet excited state [Hemmila, 2005], which is 
thought to lead to prolonged fluorescence lifetime.  The lanthanide terbium generates a 
millisecond-long lifetime decay [Nitz, et al., 2004], which is orders of magnitude longer 
than those of other fluorescent entities, enabling time-resolved lifetime analyses and 
time-resolved distance measurements (via Förster resonance energy transfer (FRET)) 
between donor and acceptor molecules [Allen, et al., 2006, Sandtner, et al., 2007, 
Rajapakse, et al., 2009, Hagan and Zuchner, 2011].  In addition, excitation and 
emission occur at wavelengths in the near infrared range, separate from naturally-
occurring biological fluorophores [Werts, et al., 1997, 2000, Hebbink, et al., 2003].  
These attributes of lanthanides permit monitoring of the lanthanide-labeled protein in a 
variety of biological matrices that may contain interfering fluorophores.  In addition, 
FRET distance measurements using lanthanides may be amongst the longest 
measured [Mathis, 1993], enabling the analysis of longer-range donor-acceptor 
distances than those using other FRET partners. 
Although fluorescence analyses may be performed using tryptophans that are 
already in the protein of interest [Allen and McLendon, 2006], site-specific introduction 
of an exogenous fluorophore into the protein of interest may be beneficial.  Site-specific 
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incorporation confers the ability to probe a specific region of the protein of interest 
where a tryptophan may not exist.  Fluorescein and the lanthanide terbium meet many 
of the aforementioned criteria [Brannon and Magde, 1978, Ge, et al., 2004, Rajapaske, 
et al., 2009], making them ideal probes for evaluating in vitro protein-protein 
interactions. 
 
1.5.2 Utility of Lanthanides in NMR 
Lanthanides are also useful biomolecular NMR probes due to their ability to 
induce local paramagnetic relaxation enhancement (PRE), pseudocontact chemical 
shifts (PCS), and residual dipolar couplings (RDC) [reviewed in Clore and Iwahara, 
2009].  PRE arises from the paramagnetic center’s ability to elicit a local perturbation of 
the applied magnetic field; PRE is an enhanced relaxation as the proton re-orients its 
spin in the direction transverse (T2) to that of the applied magnetic field.  PCS result 
when the paramagnetic center’s unpaired electrons relax in the magnetic field and 
impact neighboring nuclear spins, which are manifest in a chemical shift observed in the 
NMR spectrum.  RDC is a frequency component of the relaxing proton where the 
dipolar coupling between two spins is incompletely averaged, yielding a residual dipolar 
coupling, a frequency that can be converted to distance from the paramagnetic center 
[Saupe and Englert, 1963]. 
Lanthanide-induced PRE and RDC can yield peak shifts on the order of 4 or 
more nanometers (nm) [Otting, 2008].  Some lanthanides can induce local and long-
range PRE and PCS [Iwahara and Clore, 2006, Otting, 2008, Madl, et al., 2009].  
Therefore, PRE, PCS, and RDC facilitate elucidation of dynamics of relatively larger 
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proteins as well as the role of amino acids involved in a specific protein-protein 
interaction in NMR [Clore and Iwahara, 2009].  Finally, PRE, RDC, and PCS are 
determined relative to the paramagnetic center [Solomon, 1955, Bloembergen and 
Morgan, 1961, Guéron, 1975, Bertini, et al., 2002], therefore, the lanthanide needs to be 
site-specifically incorporated into the protein of interest. 
 
1.5.3 Small Molecule Lanthanide Chelators 
Small  molecule lanthanide chelators such as ethylenediaminetetraacetic acid 
(EDTA) and its derivatives 1,4,7,10-tetraazacyclo-dodecane-1,4,7,10-tetraacetic acid 
(DOTA) and diethylenetriaminepentaacetic acid (DTPA), (Figure 1.1) have been used 
for decades for their attomolar lanthanide binding affinity [Cacheris, et al., 1987] and for 
the superior luminescence intensities of their lanthanide complexes [Brittain, et al., 
1976, Horrocks, 1993]. 
Thiol-reactive derivatives of small molecule lanthanide chelators such as 
dipicolinic acid, DOTA, and their derivatives have been employed to react with a 
protein’s available cysteines [Poupart, et al., 2006, Su, et al., 2008, Häussinger, et al., 
2009, Almeida, et al., 2011, Zhang, et al., 2011].  Where only one reactive cysteine is 
present, lanthanide chelation for NMR can generate chemical shifts of substantial 
magnitude and facilitate deconvolution of spectra to yield structural information [Otting, 
et al., 2008].  In most cases, however, the protein of interest contains multiple cysteines 
and/or they are critically involved in disulfide bond formation, or other secondary 
structure stabilizing events and thus cannot be mutated to other amino acids to reduce 
non-specific incorporation.  Additionally, because PRE, RDC, and PCS are determined 
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relative to the paramagnetic center [Solomon, 1955, Bloembergen and Morgan, 1961, 
Guéron, 1975, Bertini, et al., 2002], lanthanide chelators that are amine- or carboxyl- 
reactive do not confer sufficient site-specificity to determine accurate PRE, RDC, and 
PCS.  Survivin is a cancer drug target which is thought to lack a traditional hydrophobic 
drug pocket; the utility of site-specific lanthanide incorporation to elucidate lowly-
populated states that Survivin adopts upon binding its protein partners such as histone-
3 may reveal druggable pockets amenable to therapeutic intervention. 
Small-molecule lanthanide chelators have been synthesized, however, the 
syntheses required numerous steps, were performed under organic, not aqueous 
conditions, and only yielded chelators that were thiol-reactive [Saha, et al., 1993, Ge 
and Selvin, 2003, Ge, et al., 2004, Häussinger, et al., 2009].  Synthesis of a small 
molecule chelator amenable to click chemistry (described below) was demonstrated 
[Martin, et al., 2010], however, the synthesis required many steps and utilized organic 
reagents; in addition, the chelator was clicked into a synthetic azide-containing peptide 
rather than an azide-containing protein target.  To overcome these current limitations, 
we proposed to synthesize, using aqueous conditions, in two steps, a small-molecule 
lanthanide chelator amenable to click chemistry-mediated, site-specific incorporation 
into the target protein, Survivin.  
 
1.6 Click Chemistry  
The reaction between an azide and a terminal alkyne to generate a 
cycloadducted product was first described as a 1,3-dipolar cycloaddition in 1961 
[Huisgen, 1961].  More recently, the 1,3-dipolar cycloaddition has been optimized as a 
14 
 
DTPA (diethylenetriaminepentaacetic acid)EDTA (ethylenediaminetetraacetic acid)
DOTA (1,4,7,10-tetraazacyclo-dodecane-
1,4,7,10-tetraacetic acid)
 
 
 
Figure 1.1: Chemical structures of small-molecule lanthanide chelators 
ethylenediaminetetraacetic acid (EDTA), 1,4,7,10-tetraazacyclo-dodecane-1,4,7,10-
tetraacetic acid (DOTA), and diethyelentriaminepentaacetic acid (DTPA). 
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Figure 1.2: Schematic of a general copper-free click chemistry reaction between an 
azide-containing molecule and a cyclooctyne-containing molecule to generate a 1,4-
disubstituted triazole-containing molecule. 
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“click chemistry” reaction [Kolb, et al., 2001], because it utilizes relatively straightforward 
facile reaction conditions to generate single products under mild reaction conditions and 
in high yields using common reagents.  One drawback to this approach, however, is that 
this click chemistry reaction between a terminal alkyne and an azide requires high 
amounts of copper to catalyze the formation of the triazole-containing cycloadduct.  
Copper-mediated click chemistry has been performed in vitro to evaluate the in 
vivo activities of proteins of interest [Speers & Cravatt, 2004].  The millimolar copper 
concentration required, however, gave rise to relatively harsh experimental conditions 
that were not conducive to mimicking physiologically-relevant settings and, because 
cells contain no free copper, copper may initiate redox cycling, which may cause cell 
death [Kim, et al., 2008].  Therefore, copper-free click chemistry reactions may be 
preferred over those requiring high copper concentrations [Jewett and Bertozzi, 2010], 
to evaluate proteins in vitro and in vivo.   
Because of their ring strain and the energy contained within the carbon-carbon 
triple bond, cyclooctynes exhibit excellent reactivity towards azides to specifically form 
triazole cycloadducts in the absence of a copper catalyst [Gordon, et al., 2012], as 
depicted in Figure 1.2.  Due to their superior reactivity over terminal alkynes, 
cyclooctynes have become useful tools for completing copper-free click chemistry 
reactions under physiologically-relevant reaction conditions (Gordon, et al., 2012).    
Consequently, copper-free click chemistry has been pursued to chelate a lanthanide 
site-specifically within the target protein (chapter 4). 
One advantage of a click chemistry reaction is that the azide or alkyne moiety 
can be on the reporter molecule and its complementary reactive group can exist in a 
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specific site within a protein of interest.  Through tRNA synthetase cloning and 
mutagenesis strategies, Archaea bacterial expression systems have been optimized to 
recognize and incorporate unnatural amino acids [Xie, et al., 2007, Chin, et al., 2002, 
Deiters and Schultz, 2005, Brustad et al., 2008, Young and Schultz, 2010], such as the 
phenylalanine analog para-azidophenylalanine (paF). The unnatural amino acyl tRNA 
synthetase charges a tRNA with paF for site-specific incorporation into the protein at the 
amber stop codon [Chin, et al., 2002].  The result is a protein with a reactive azide in a 
specific position within the protein, which can undergo click chemistry-mediated 
incorporation with an alkyne-containing reporter molecule.  The protein can then be site-
specifically labeled, using click chemistry, with a fluorescent and/or paramagnetic label.  
Site-specific incorporation may be determined using mass spectrometry approaches.  
The fluorescently- or paramagnetically-labeled protein can then be utilized in protein-
protein interaction studies using fluorescence- and/or NMR-based approaches.  
Fluorescence-based analyses may include monitoring steady-state fluorescence 
intensity, fluorescence lifetime, and/or FRET; NMR-based analyses may include protein 
structure determination and analyzing the conformational changes the protein adopts as 
its protein binding partner is added. 
 
1.7 Objectives of the Efforts Described in this Dissertation 
Considering the advantages conferred upon lanthanide chelation to augment 
NMR-mediated protein structure determination, and the utility of fluorescence-based 
approaches to facilitate monitoring of protein-protein interactions, the central hypothesis 
of the efforts described in chapters 3 and 4 of this dissertation was that site-specific 
18 
 
labeling of the protein of interest, Survivin, with a fluorescent or paramagnetic tag may 
be used to monitor protein-protein interactions. 
The central hypothesis of the efforts described in chapter 5 of this dissertation 
was that high-throughput screening using fluorescence polarization is a viable platform 
to identify candidate molecules of a specific non-enzymatic protein-peptide interaction, 
Survivin-histone-3. 
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1.8 Statement of Purpose 
 
One strategy to bring therapies to the clinic is to use structure-aided design to 
synthesize a small molecule inhibitor of the protein target’s function.  This strategy may 
be particularly advantageous for inhibiting assembly of non-enzymatic proteins and/or 
architectural/scaffold proteins.  To facilitate this, it is attractive to expand the utility of x-
ray crystallography, NMR, or fluorescence-based structure determination methods.  
One strategy to achieve this is to incorporate a lanthanide into the protein of interest.  
Lanthanides have unique fluorescence and paramagnetic properties that can be 
harnessed to expand structure determination methods, which may improve efforts at 
structure-aided drug design.  The efforts of this research aimed to merge site-directed 
mutagenesis and copper-free click chemistry to label the protein of interest (Survivin, in 
this case) with a fluorophore or lanthanide chelator, with the purpose of augmenting 
efforts at structure-aided drug design. 
A strategy to identify small molecule leads that may be suitable for structure-
aided drug design is to screen small molecule libraries containing candidate molecules 
that may have suitable pharmacological properties.  In this regard, our research 
objective was to establish a fluorescence polarization-based platform to identify 
inhibitors of a specific protein-peptide interaction, namely the Survivin-histone-3 protein-
peptide interaction.  
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1.9 Specific Aims 
 
Working under the hypothesis that site-specific labeling of the Survivin protein with a 
fluorescent tag may be accomplished using copper-free click chemistry and unnatural 
amino acid incorporation, the specific aim of the experiments described in chapter 3 
was to evaluate the utility of click chemistry to label the Survivin protein with a 
fluorophore in order to monitor protein-protein interactions of Survivin with its protein 
binding partners. 
 
Working under the hypothesis that site-specific labeling of the Survivin protein with a 
paramagnetic tag may be accomplished using copper-free click chemistry and unnatural 
amino acid incorporation, the specific aim of the experiments described in chapter 4 
was to synthesize a small molecule lanthanide chelator amenable to copper-free click 
chemistry in order to perform NMR-based structural analyses of Survivin with its protein 
binding partners. 
 
Working under the hypothesis that high-throughput fluorescence polarization-based 
screening of chemical compound libraries may serve as a platform to identify candidate 
molecules of specific protein-protein interactions, the specific aim of the experiments 
described in chapter 5 was to design a fluorescence polarization assay to rapidly screen 
chemical libraries in order to identify candidate inhibitors of the Survivin-histone-3 
protein-protein interaction. 
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Chapter 2. Materials and Methods 
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2.1 Chemicals 
Europium trichloride (EuCl3), lanthanum trichloride (LaCl3), terbium trichloride 
(TbCl3), ytterbium trichloride (YbCl3), ethylenediaminetetraacetic acid (EDTA), 
diethylenetriaminepentaacetic acid (DTPA), and 1-ethyl-3-(3-dimethylamino-propyl)-
carbodiimide (EDC) were procured from Sigma (St. Louis, MO); dibenzylcyclooctyne 
(DBCO) conjugated to fluorescein (DBCO488) and DBCO-amine were purchased from 
Click Chemistry Tools (Scottsdale, AZ).  Para-azidophenylalanine (paF) (Bachem, 
Torrance, CA) was dissolved in 100% acetic acid prior to the addition of water to 
achieve 80% (v/v) acetic acid and 100 mM paF.  All other reagents were of the highest 
grade commercially available. 
 
2.2 Determination of Fluorescence Excitation and Emission Maxima or Steady-
State Fluorescence Intensities 
Excitation and emission maxima and/or steady-state fluorescence intensities of 
the following compounds were determined at room temperature (22f°C) using a quartz 
cuvette and a Fluoromax4 Fluoro-Hub spectrofluorometer (HORIBA Jobin Yvon, 
Edison, NJ), with the Origin FluorEssenceTM software package (HORIBA Jobin Yvon): 
A) 1 µM Survivin1-120 labeled at the extreme C-terminus with DBCO488 
(DBCO488-CtermpaFsurv1-120) in 50 mM Tris, pH 7.46 at 22˚C, 500 
mM sodium chloride, 2 mM β-mercaptoethanol. 
B) 10 mM DTPA, 40 mM terbium chloride, and 10 mM metallated DTPA in 
100 mM MES, pH 5.5. 
C) 193.5 µM DBCO-amine in 3.2% (v/v) DMSO in 100 mM MES, pH 5.5. 
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D) 10 mM clickable chelator in 100 mM MES, pH 5.5. 
E) Fractions (3.5 mL) collected from the anion exchange chromatographic 
separation of the metallation reaction, using an excitation of 350 nm.  
Emission was monitored from 400-800 nm.   
F) G10 Sephadex chromatography fractions (~4 mL) collected from the 
amide coupling reaction using two different experimental conditions.  
Terbium emission was monitored from 400-800 nm using an excitation 
of 350 nm.  DBCO-amine emission was monitored from 300-800 nm 
using an excitation of 259 nm.   
G) 100 nM carboxyfluorescein-labeled histone-3 (H3*) peptide in 100 mM 
potassium phosphate, pH 7.5.  The excitation scan was from 300 to 
500 nm and the emission scan was from 520 to 750 nm. 
 
2.3 Synthetic Peptides 
The following peptides were synthesized (Kansas State University, Jon Tomich 
laboratory); fam refers to carboxyfluorescein: 
Histone-3 (abbreviated H3): Ac-ARTKQTARKS-CONH2 
Fluorescently-labeled Histone-3 (abbreviated H3*): Ac-ARTKQTARKS-K(fam)-
CONH2 
Peptides were synthesized on an ABI Model 431 peptide synthesizer (Applied 
Biosystems, Foster City, CA) on a 0.1 mmol scale using solid phase peptide chemistry 
on 4-(2,4-dimethoxyphenyl-Fmoc-aminomethyl) phenoxyacetyl-norleucyl-cross-Linked 
Ethoxylate Acrylate Resin (Peptides International Inc., Louisville, KY) using Fmoc (N-(9-
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fluorenyl)methoxycarbonyl)/tert-butyl chemistry [Kempe and Barany, 1996].  The 
carboxyamide is yielded at the C-terminus using this resin.  Fmoc amino acids were 
obtained from Anaspec, Inc. (Fremont, CA).  The peptides’ N-termini were acetylated on 
the resin and subsequently cleaved using trifluoroacetic acid as previously described 
[Sukthankar, et al., 2013].   Then, the released peptide product was washed with diethyl 
ether, re-dissolved in deionized, reverse osmosis-treated and distilled water, and then 
lyophilized. For the fluorescein incorporating variants, N-α-Fmoc-N-ε-(5-
carboxyfluorescein)-L-lysine was manually coupled to the resin using HOBt/HBTU 
chemistry before automating the synthesis as before [Iwamoto, et al., 1994].  Peptides 
were dried in vacuo and characterized on a Bruker Ultraflex III matrix-assisted laser 
desorption ionization time of flight mass spectrometer (MALDI TOF/TOF) (Bruker 
Daltonics, Billerica, MA) using 2,5-dihydroxybenzoic acid matrix (Sigma).  
Variable masses of fluorescently-labeled histone 3 peptide (H3*) were 
reconstituted in 100 mM potassium phosphate, pH 7.5, containing 100 µg/mL bovine 
gamma globulin and 0.02% (w/v) sodium azide. Variable masses of unlabeled histone-3 
peptide were reconstituted in 100 mM potassium phosphate, pH 7.5, devoid of bovine 
gamma globulin and sodium azide.   
 
2.4 Synthesis of Survivin Protein Comprised of Amino Acids 1 – 120 
Survivin1-120 Cloning, Transformation, and Over-Expression 
Full-length Survivin (amino acids 1 – 142) contains a hydrophobic C-terminal 
domain spanning amino acids 121 – 142 [Chantalat, et al., 2000]; consequently, a 
Survivin construct comprised of amino acids 1 – 120 was generated as follows: the 
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cDNA of Birc5, the gene encoding full-length wild type human Survivin, was obtained 
from OriGene, in the pCMV6-XL4 vector (OriGene, Rockville, MD).  An NdeI restriction 
site was cloned into the Birc5 gene upstream of the 5’ ATG nucleotide; a XhoI 
restriction site was cloned into the Birc5 gene after Survivin amino acid 120.  Using the 
NdeI and XhoI restriction sites, Birc5 was cloned into the pET-15b vector (Novagen, 
Billerica, MA).  The construct was confirmed by sequencing.  The encoded His6 tag and 
thrombin cleavage site (LVPRGS) immediately upstream of the Survivin gene’s start 
site were utilized for protein purification.  Plasmid containing the Survivin gene 
encoding amino acids 1-120 was transformed into BL21*DE3 E. coli competent cells 
according to manufacturer’s specifications (Invitrogen).  Transformed cells were plated 
on Luria-Bertani (LB) agar containing 100 µg/mL ampicillin and were grown overnight 
at 37°C.  The next day, a single colony was picked to inoculate a starter culture (~70 
mL) of LB broth containing 100 µg/mL ampicillin, which was then incubated overnight 
at 37°C with shaking at 225 revolutions per minute (rpm).  The next day, the starter 
culture was transferred to Terrific Broth (TB) supplemented with 8 mL of 100% glycerol 
per liter and 100 µg/mL ampicillin, and incubated at 37°C with shaking at 225 rpm until 
an absorbance of 0.6-0.8 at 600 nm was achieved (~5 hours’ incubation).  The culture 
was induced with 1 mM IPTG and incubation resumed at 25°C at 160 rpm for 18-24 
hours.  After incubation, cells were collected by centrifugation at 6000xg for 10 minutes 
at 4°C; cell pellets were stored at -80°C until protein purification was performed.   
Purification by Fast-Phase Liquid Chromatography - Survivin1-120 
Purification of Survivin1-120 was conducted as for all Survivin1-120 mutants 
(described in a subsequent section) with the following additional steps: after imidazole-
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mediated elution of His6-Survivin1-120 from the nickel-NTA column, fractions containing 
His6-Survivin1-120 were pooled and dialyzed against 100 mM potassium phosphate, pH 
7.5, with gentle stirring, at 2-8˚C, for a minimum of 2 hours per buffer exchange.  
Dialysis was performed until an imidazole concentration of 1 mM or lower was achieved, 
a concentration of imidazole that is thought not to interfere with thrombin enzyme 
activity (Novagen). After dialysis, thrombin cleavage was performed according to 
manufacturer’s specifications (biotinylated thrombin from Novagen, NeutrAvidin from 
Thermo Fisher, Waltham, MA).  Following thrombin cleavage, the sample, in 100 mM 
potassium phosphate, pH 7.5, was applied at a flow of 0.1-0.25 mL/min to an 
equilibrated HisTrap FF 5 mL nickel column (GE Healthcare) to separate the thrombin-
cleaved Survivin1-120 from uncleaved Survivin1-120 and/or the His6 tag.  Cleaved Survivin1-
120, which no longer binds the nickel column, was collected in the column wash, in 9-mL 
fractions.  Fractions exhibiting absorbance at 280 nm in the column wash were 
subjected to sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) 
separation followed by staining with Coomassie, then concentrated.   
Survivin1-120 was concentrated using either 15-mL Amicon Ultra centrifugal filters 
(Ultracel 3000 MWCO, Millipore) spun with successive cycles at 6000xg for 10 minutes 
at 4˚C or with a 400-mL stirred cell concentrator at 75 pounds per square inch (psi) with 
a 3000 molecular weight cutoff (MWCO) filter, at 2-8˚C, according to manufacturer’s 
specifications (EMD Millipore).  Survivin1-120 concentration was determined using a 
NanoDrop 1000 spectrophotometer (Thermo Fisher) controlled by ND-1000 software 
(version 3.8.1, Thermo Fisher).  A molar extinction of 16500 M-1cm-1 (ProtParam Tools, 
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ExPASy, Swiss Institute of Bioinformatics) was used.  Survivin1-120 was stored at -80˚C 
until analysis. 
 
Purification by Manual Column Application and Elution – Survivin1-120 
An approximately 100-mL HisPurTM nickel-NTA resin column was poured 
according to manufacturer’s specifications (Thermo Fisher) and contained within an 
enclosed cold cabinet (2-8˚C).  The column was equilibrated with loading buffer prior to 
the addition, by gravity, of the aforementioned supernatant from the ultracentrifugation 
step containing His6-Survivin1-120.  The column was washed with loading buffer (50 mM 
Tris, pH 8.0 at 4°C, 500 mM sodium chloride, 2 mM β-mercaptoethanol) for 
approximately 20 column volumes, during which time fractions were not collected.  After 
washing, elution of His6-Survivin1-120 was achieved using a gradient maker containing 
500 mL loading buffer in chamber A and 500 mL loading buffer containing 400 mM 
imidazole in chamber B.  The gradient was carried out with gentle stirring at 2-8°C, at a 
flow of 1.0 mL/min during which time approximately ~9-mL fractions were collected.  
Fractions exhibiting absorbance at 280 nm in the elution phase of the method were 
analyzed for Survivin presence by SDS-PAGE separation followed by Coomassie 
staining.  Fractions containing Survivin were pooled and dialyzed, and thrombin 
cleavage, purification, and concentration were performed as for the Fast-Phase Liquid 
Chromatography-mediated purification.    
2.5 SDS-PAGE, Coomassie Staining, Western Blotting, UV Illumination 
FPLC fractions exhibiting absorbance at 280 and/or 500 nm were prepared for 
SDS-PAGE separation by combining 20:1 Laemmli Sample Buffer (Bio-Rad, Hercules, 
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CA):β-mercaptoethanol and sample in a 1:1 ratio, heating to 95°C for 5 minutes, and 
then spinning briefly prior to adding to 4-15% gel (Bio-Rad 456-1084) or homemade 15, 
18, or 20% resolving gel with a 4% stacking gel.  Running buffer comprised of 1x 
Tris/Glycine/SDS was prepared from a 10x stock Tris/Glycine/SDS Buffer (Bio-Rad).   
For Coomassie analysis after SDS-PAGE separation, the gel was gently washed 
3 times on a rotating platform at room temperature for 5 minutes per wash with MilliQ 
water, then stained with 0.05% (w/v) Coomassie R-250 (Thermo Fisher Scientific) in 
4:5:1 methanol:water:acetic acid for 45-60 minutes with gentle agitation on a rotating 
platform at room temperature.  Stain was decanted and the gel destained with 30% (v/v) 
methanol, 10% (v/v) acetic acid in water with gentle agitation on a rotating platform at 
room temperature.   
For western blotting after SDS-PAGE separation, the gel was transferred onto a 
0.2-µm nitrocellulose membrane (Bio-Rad) and electrophoresed for 60 minutes at 100 V 
prior to blocking with 5% (w/v) milk in 1x Tris-buffered saline (TBS) for 60 minutes with 
gentle rocking.  Three 5-minute washes were performed in 1xTBS-T (TBS with 0.1% 
(v/v) Tween-20) at room temperature, with gentle rotation on a rotating platform.  
Subsequently, mouse α-human Survivin primary antibody (Catalog number 2802S, Cell 
Signaling, Danvers, MA) at 1:1000 dilution was applied in 5% (w/v) milk in 1xTBS-T and 
incubated at 2-8°C with gentle rocking for a minimum of an overnight.  Three 5-minute 
washes were performed in 1xTBS-T at room temperature, with gentle rotation on a 
rotating platform.  Then, horseradish peroxidase (HRP)-conjugated goat α-mouse 
secondary antibody (Thermo Fisher Scientific) was applied at 1:10000 dilution in 5% 
(w/v) milk in 1xTBS-T and incubated at room temperature with gentle rocking for 60 
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minutes.  Subsequently, the blot was incubated in Enhanced Chemiluminescent (ECL) 
reagent (Pierce, Rockford, IL) for 5 minutes with gentle rocking, at room temperature, 
protected from light.  Blots were exposed to radiography film (BlueBasic AutoRad Film, 
BioExpress, Kaysville, UT) and developed using a film processor (SRX-101A, Konica 
Minolta, Wayne, NJ). 
For analysis of fluorescence after SDS-PAGE separation, the gel was transferred 
to an 8-watt, 0.4 Amp, 100-115V-60 Hertz Benchtop 3UV™ Transilluminator (UVP, 
Upland, CA) and exposed to an excitation wavelength of 254 nm. 
 
2.6 Whole-peptide Mass Spectrometry 
For protein mass measurement, 10 microliters of 0.4 mg/mL thrombin-cleaved 
Survivin1-120 protein solution were desalted on a C8 reversed phase column (ZC-GU-
C8SBW 320S guard column 1 cm x 0.32 mm, Micro-Tech Scientific, Vista, CA). After 
washing the column with 0.1% (v/v) formic acid for 20 minutes at a flow rate of 0.5 
mL/min, the flow of the column was diverted to the stage of a Linear Trap Quadrupole – 
Fourier Transform (LTQ FT) mass spectrometer and the protein was eluted using a 0-
70% (v/v) acetonitrile gradient in 0.1% (v/v) formic acid at a flow rate of 300 nL/min. The 
mass spectrometer was operated in the positive ion mode, to acquire in full mass scan 
in the m/z range of 400 to 2000 atomic mass units (amu).  For mass measurement, the 
spectrum was deconvoluted using the Biomass deconvolution algorithm provided in the 
Xcalibur (Thermo Fisher Scientific) software set of applications.  
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2.7 Synthesis of paF-containing Survivin1-120 Proteins 
Mutagenesis of the Survivin Gene for the Synthesis of paF-containing 
Survivin1-120 Proteins 
The pET-15b-His6-LVPRGS-Birc51-120 construct was used as the template to 
generate paF-containing Survivin1-120 mutants as follows: primers for site-directed 
mutagenesis were designed according to the recommendations in the Stratagene site-
directed mutagenesis protocol.  The codon for the amber stop (tag) replaced the 
existing codon wherever paF was inserted as depicted in Figure 2.1, using primers 
shown in Table 2.1.  Seven Survivin mutants were generated (Figure 2.1) by performing 
site-directed mutagenesis with pET-15b-His6-LVPRGS-Birc51-120 as template.  After 
polymerase chain reaction (PCR), DpnI digestion was performed and putative mutant 
plasmids were purified by gel extraction from an ethidium bromide-containing 0.8% 
(w/v) agarose gel in 1x Tris-acetate-EDTA (Sigma) or 1x Tris-borate-EDTA (Sigma).  
Putative mutant plasmids were transformed into XL1Blue competent cells (Invitrogen, 
Grand Island, NY) according to manufacturer’s recommendations.  Transformed cells 
were plated on LB agar containing 100 µg/mL ampicillin and grown overnight at 37°C.  
A single colony from each mutant was picked and grown in LB broth containing 100 
µg/mL ampicillin overnight at 37°C with shaking at 225 rpm.  Plasmid preparation was 
performed according to manufacturer’s specifications (Qiagen, Valencia, CA).  Aliquots 
of plasmids were sent for sequencing (ACGT, Wheeling, IL).  Sequences were analyzed 
using Bio-  
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W10
F101 F93G99
W67
position 121
N-termini
Modified from PDB: 1E31 [Chantalat, et al., 2000]
 
Figure 2.1: Full-length Survivin, amino acids 1-142, in its homodimeric conformation, 
modeled in Chimera [University of California – San Francisco], modified from the 
Protein Data Bank entry 1E31 [Chantalat, et al., 2000].  Positions of paF insertion or 
substitution into the Survivin protein are depicted.  paF insertions were at the extreme 
N- (position 0) and C-termini (position 121); paF substitutions were of tryptophans 10 
and 67, phenylalanines 93 and 101, and glycine 99. 
 
32 
 
F 5'-ggc agc cat atg tag atg ggt gcc cc-3'
R 5'-gg ggc acc cat cta cat atg gct gcc-3'
F 5'-g ccc cct gcc tag cag ccc ttt ctc-3'
R 5'-gag aaa ggg ctg cta ggc agg ggg c-3'
F 5'-g ctg gaa ggc tag gag cca gat gac g-3'
R 5'-c gtc atc tgg ctc cta gcc ttc cag c-3'
F 5'-ctt tct gtc aag aag cag tag gaa gaa tta acc ctt gg-3'
R 5'-cc aag ggt taa ttc ttc cta ctg ctt ctt gac aga aag-3'
F 5'-cag ttt gaa gaa tta acc ctt tag gaa ttt ttg aaa ctg gac aga g-3'
R 5'-c tct gtc cag ttt caa aaa ttc cta aag ggt taa ttc ttc aaa ctg-3'
F 5'-tta acc ctt ggt gaa tag ttg aaa ctg gac aga gaa-3'
R 5'-ttc tct gtc cag ttt caa cta ttc acc aag ggt taa-3'
F 5'-acc aac aat aag tag gga tcc ggc tgc taa c-3'
R 5'-g tta gca gcc gga tcc cta ctt att gtt ggt-3'
G99paF
F101paF
paF at C-terminus
paF at N-terminus
W10paF
W67paF
F93paF
 
 
 
Table 2.1: Primer sequences for site-directed mutagenesis of the Survivin gene 
encoding amino acids 1-120, to insert (at the extreme N- and C- termini) or substitute 
(at positions 10, 67, 93, 99, and 101) paF at the amber stop codon (tag) into pET-15b-
His6-LVPRGS-Birc51-120. F: Forward primer sequence; R: Reverse primer sequence. 
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Edit Sequence Alignment Editor (version 7.1.3.0, Ibis Biosciences, Carlsbad, CA).  The 
remaining plasmid stocks were stored at -20°C.  
 
Unnatural tRNA Synthetase Plasmid Preparation 
The plasmid containing the Methanococcus jannaschii (also referred to as 
Methanocaldococcus jannaschii) tRNA synthetase that recognizes paF (Ryu and 
Schultz, 2006) was procured from Peter Schultz’s laboratory and transformed into 
Top10 cells (Invitrogen) according to manufacturer’s specifications (Invitrogen).  
Transformed cells were plated on LB agar containing 20 µg/mL chloramphenicol and 
grown overnight at 37°C.  A single colony was picked and grown in LB broth containing 
20 µg/mL chloramphenicol overnight at 37°C with shaking at 225 rpm.  Plasmid 
preparation was performed according to manufacturer’s specifications (Qiagen) and 
DNA concentration determined.  Plasmid was sent for sequencing (ACGT).  Sequences 
were analyzed using BioEdit; the remaining plasmid stock was stored at -20°C.  
 
Preparation of Competent Cells Encoding Unnatural tRNA Synthetase 
To incorporate the unnatural amino acid paF into the amber stop codon during 
translation of the Survivin mRNA, the plasmid that encodes the amber stop codon tRNA 
and the unnatural amino acyl tRNA synthetase that recognizes the unnatural amino 
acid, is transformed into competent cells.  Subsequently, the plasmid encoding the 
Survivin gene containing the amber stop is transformed into these competent cells that 
encode the amber suppressor tRNA and unnatural amino acyl tRNA synthetase. 
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Although DH10B E. coli were originally used to incorporate the unnatural amino 
acyl tRNA synthetase plasmid into the host chromosome, DH10B cells express the 
unnatural tRNA synthetase gene under a constitutive promoter.  Compared to 
BL21*DE3 E. coli cells, DH10B E. coli confers inferior protein yield.  Although 
BL21*DE3 E. coli cells may confer improved yield compared to DH10B cells, BL21*DE3 
E. coli can aberrantly recognize and insert arginine into the amber stop codon, yielding 
protein that contains arginine in place of the unnatural amino acid paF, which may result 
in improperly folded protein and/or protein that cannot participate in a copper-free click 
chemistry reaction.   
Methanococcus jannaschii tRNA and tRNA synthetase-containing plasmid was 
transformed into BL21*DE3 E. coli competent cells (Invitrogen) for the preparation of 
amber suppressor tRNA and tRNA synthetase-containing competent cells according to 
the Sambrook and Russell protocol for the preparation of E. coli competent cells using 
calcium chloride (Sambrook & Russell, Molecular Cloning, 3rd Edition, volume 1, 
protocol 25).  Competent cells were stored at -80°C. 
Transformation and Over-Expression - Survivin1-120 Mutants 
  Plasmids encoding mutant Survivin proteins containing paF were 
transformed into BL21*DE3 E. coli competent cells containing the amber suppressor 
tRNA and unnatural amino acyl tRNA synthetase using the same transformation 
protocol as commercially-available BL21*DE3 E. coli competent cells (Invitrogen). 
Transformed cells were plated on LB agar containing 100 µg/mL ampicillin and 20 
µg/mL chloramphenicol and were grown overnight at 37°C.  The next day, a single 
colony was picked to inoculate a 70-mL starter culture of LB broth containing 100 µg/mL 
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ampicillin and 20 µg/mL chloramphenicol, which was then incubated overnight at 37°C 
with shaking at 225 rpm.  The next day, the starter culture was transferred to 1L of LB 
broth containing 100 µg/mL ampicillin and 20 µg/mL chloramphenicol and incubated at 
37°C with shaking at 225 rpm until an absorbance of 0.6-0.8 at 600 nm was achieved 
(~5 hours’ incubation).  The culture was simultaneously induced with 1 mM IPTG, 
protected from UV exposure using aluminum foil to reduce azide activation, and 100 µM 
paF was added.  Incubation resumed at 25°C at 160 rpm for 18-24 hours, protected 
from light.  After incubation, cells were collected by centrifugation at 6000xg for 10 
minutes at 4°C, protected from light. Cell pellets were stored at -80°C until protein 
purification was performed.  A negative control sample was executed identically in the 
absence of paF to evaluate the fidelity with which paF is incorporated at the amber stop 
codon. 
  
Purification - Survivin1-120 Mutants 
Cell pellets were placed on ice, protected from light, and gently stirred until 
thawed in the presence of lysis buffer (50 mM Tris, pH 8.0 at 4°C, 500 mM sodium 
chloride, 2 mM β-mercaptoethanol, and 1 mM phenylmethylsulfonyl fluoride (PMSF)) at 
5 mL lysis buffer per gram cell pellet; lysis was achieved by sonication (Ultrasonic 
Processor) and cellular debris removed by ultracentrifugation at 100,000xg for 60 
minutes at 4°C in an Optima L-100 XP Ultracentrifuge and 70 Ti rotor (Beckman 
Coulter).  The supernatant was retained and protected from light for subsequent 
chromatographic purification.   
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An ÄKTA Purifier 100 / 10 FPLC controlled by UNICORN software (version 5.20 
General Electric Healthcare, Piscataway, NJ), was used for protein purification in an 
enclosed cold cabinet (2-8˚C).  Protein was shielded from light throughout the 
purification.  For all chromatographic steps, columns were equilibrated with a sufficient 
volume of loading buffer required to achieve stable baseline, as monitored by 
absorbance in the UNICORN program.  The aforementioned supernatant was filtered 
through an Acrodisc® 32 mm syringe filter with 0.2 µm Supor® non-pyrogenic 
membrane (Pall Corporation, Cornwall, United Kingdom) prior to applying the filtrate to 
an equilibrated HisTrap FF 5 mL nickel column, used in conjunction with loading buffer.  
The protein was loaded at 0.1 – 0.25 mL/min.  Unbound protein was removed by 
washing the column with 20-30 column volumes of loading buffer.  Elution of His6-
tagged mutant Survivin1-120 was achieved using 0-100% loading buffer containing 400 
mM imidazole; the gradient was carried out over 10 column volumes during which time 
9-mL fractions were collected.  Fractions exhibiting absorbance at 280 nm in the elution 
phase of the method were separated by SDS-PAGE then analyzed for Survivin 
presence by Coomassie staining and western blotting.     
Mutant Survivin1-120 proteins were concentrated and the concentrations 
determined as described above.  Mutant Survivin1-120 proteins were stored at -80˚C until 
analysis. 
 
2.8 Copper-free Small Molecule Click Chemistry 
Absorbance scans of 100 mM paF in  80% (v/v) acetic acid, 1 mM DBCO488 in 
100% DMSO, and 1 µM DBCO488-labeled Survivin1-120 at the extreme N-terminus 
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(DBCO488-NtermpaF-Survivin1-120) in loading buffer were carried out at slow speed 
(200 nm/min), at room temperature, using a quartz cuvette and the appropriate blanking 
solutions from 800-200 nm in a Cary50 Bio UV-Vis Spectrophotometer (Varian, Agilent 
Technologies, Santa Clara, CA), under control of Varian UV software, version 3.00(303) 
(Agilent Technologies).   
After determining the absorbance maxima of 100 mM paF in 80% (v/v) acetic 
acid and 1 mM DBCO488 in 100% DMSO, copper-free click chemistry reactions to 
generate a cycloadducted product (Figure 2.2) were performed using paF (azide) and 
DBCO488 (alkyne) as indicated in Table 2.2.  Copper-free click chemistry reactions 
were also performed using the small molecule unnatural amino acid paF and the 
clickable chelator (DBCO-DTPA:Tb) as indicated in Table 2.2, in a 200 µL total final 
volume, with 100 mM MES, pH 5.5, as diluent.  Reactions were gently rocked, protected 
from light with aluminum foil, for 24 hours at room temperature.  Reactions were allowed 
to proceed to completion prior to analyzing 50-µL aliquots of each reaction by high-
performance liquid chromatography (HPLC).  
 
HPLC Separation of Copper-free Click Chemistry Reactions of Small 
Molecules paF and DBCO488 or DBCO-DTPA:Tb 
A Shimadzu HPLC with Shimadzu SPD-M20A diode array detector and CLASS 
VP software (LabSolutions Lite, version 5.52, Shimadzu, Kansas City, MO) and Supelco 
15 cm x 4.6 mm x 5 µm Supelcosil-LC18 column (Sigma) were used.   
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Figure 2.2: Schematic representation of the small molecule copper-free click chemistry  
reaction of para-azidophenylalanine (paF, azide) and DBCO488 (fluorescent, alkyne) to 
generate the triazole-containing fluorescent paF-DBCO488 cycloadduct (one product 
shown). 
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Molar stoichiometry 
of alkyne:azide
Final concentration 
(µM)
1:1   500, 500
  10:1 500, 50
  1:10     500, 5000
 
 
 
 
 
 
 
 
Table 2.2: Click chemistry reaction conditions between para-azidophenylalanine (azide) 
and DBCO488 (alkyne) in 100 µL or between para-azidophenylalanine (azide) and 
clickable chelator (alkyne) in a 200 µL total final volume.  Left panel: molar 
stoichiometries of alkyne and azide.  Right panel: final concentration of alkyne (left 
value) and azide (right value) in reaction. 
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  paF and DBCO488 
Mobile phases to separate copper-free click chemistry reactions between 
DBCO488 and paF consisted of A: 0.1% (v/v) trifluoroacetic acid (TFA) in water, B: 
100% acetonitrile (ACN).  The flow was 1.5 mL/min; the gradient was 10-90% B from 1-
9 minutes, 90% B from 9-15 minutes, 90-0% B from 15-16 minutes, 0% B from 16 to 22 
minutes.  During each HPLC separation of the click chemistry reactions, 1-mL fractions 
were collected.  To confirm the identity of the HPLC peaks that correspond to the 
cycloadducted product paF-DBCO488, fractions that exhibited absorbance at 280 and 
310 nm (absorbance maxima for paF) and 454 (absorbance maximum for DBCO488 in 
DMSO) were collected and dried under gentle nitrogen sparge then reconstituted in 
40% TFA in water (0.1% (v/v)): 60% acetonitrile (100%) for small-molecule mass 
spectrometry.   
paF and DBCO-DTPA:Tb 
Mobile phases to separate copper-free click chemistry reactions between 
DBCO-DTPA:Tb and paF consisted of A: 0.1% (v/v) TFA in water, B: 100% ACN.  Flow 
was 0.75 mL/min; the gradient was 0-1 min, 0% B, 1-10 min, 0-100% B, 10-16 min, 
100% B, 16-17 min, 100-0% B, 17-22 min, 0% B.  1-mL fractions that exhibited 
absorbance and retention times of the clickable chelator (DBCO-DTPA:Tb) and the 
clicked clickable chelator (the product of the click chemistry reaction between the 
clickable chelator (DBCO-DTPA:Tb) and paF) were collected. 
 
Small-molecule Mass Spectrometry of paF-DBCO488 Cycloadduct 
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An Acquity Ultra Performance Liquid Chromatograph (Waters, Milford, MA) 
controlled by MassLynx (version 4.1, Waters) was used with mobile phases A: 0.1% 
(v/v) formic acid and B: 0.1% (v/v) formic acid in 100% ACN, with a linear gradient from 
0-100% over 20 minutes, using a 2.1 x 100 mm, 1.7 µm Acquity UPLC BEH C18 
column (Waters).   
A QTOFMS (SYNAPT G1 HDMS, Waters) was operated in positive ion mode 
with electrospray ionization.  The source and desolvation temperatures were set at 
120°C and 350°C, respectively.  Nitrogen was applied as the cone gas (10 L/hr) and 
desolvation gas (700 L/hr).  TOFMS was calibrated with sodium formate and monitored 
by the intermittent injection of lock mass leucine enkeophalin in real time, generating a 
reference ion at m/z 556.2771.  The capillary voltage and cone voltage were set at 3.5 
kV and 35V, respectively.  
 
2.9 Copper-free Click Chemistry with Azide-containing Survivin 
A copper-free click chemistry reaction between Survivin1-120 labeled at the 
extreme N-terminus with paF (NtermpaF-surv1-120) and DBCO488 was performed by 
combining approximately 1 mg of NtermpaF-surv1-120 with 1.015 mg DBCO488 in 100% 
DMSO, to yield an estimated molar stoichiometry of 1:26.9; the resulting DMSO 
concentration was 2%.  The reaction was gently rocked at 2-8°C, in loading buffer, 
protected from light with aluminum foil, for 24 hours until reaction was applied to an 
equilibrated HiLoad 26/60 Superdex 200 prep grade size-exclusion column (GE 
Healthcare).  The reaction was allowed to proceed to completion.     
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A copper-free click chemistry reaction between Survivin1-120 labeled at the 
extreme C-terminus with paF (CtermpaFsurv1-120) and DBCO488 was performed by 
combining approximately 0.5 mg of CtermpaFsurv1-120 with 0.564 mg DBCO488 in 
100% DMSO (100%) to yield an estimated molar stoichiometry of 1:29.9; the resulting 
DMSO concentration was 2%.  The reaction was gently rocked at 2-8°C in loading 
buffer, protected from light with aluminum foil, for 24 hours until reaction was applied to 
an equilibrated HiLoad 26/60 Superdex 200 prep grade size-exclusion column (GE 
Healthcare).  The reaction was allowed to proceed to completion.  
 
Size-exclusion Chromatography 
An aliquot of the copper-free click chemistry reaction mix containing DBCO488 
and NtermpaF-surv1-120 in loading buffer was applied to a HiLoad 26/60 Superdex 200 
prep grade size-exclusion column (GE Healthcare) equilibrated with loading buffer, at a 
rate of 0.1 – 0.25 mL/min.  An ÄKTA Purifier 100 / 10 FPLC was used.  One and a half 
column volumes (495 mL) of loading buffer were passed over the size-exclusion column 
during which time 9-mL fractions were collected.  Absorbance was monitored at 280 
and 500 nm (the absorbance maximum of DBCO488-labeled Survivin1-120).  Fractions 
exhibiting absorbance at 280 and 500 nm were separated by SDS-PAGE and analyzed 
by Coomassie, western blotting, and UV gel illumination. 
 
2.10 Time-Domain Fluorescence Lifetime Determination  
Time-correlated single-photon counting (TCSPC) experiments utilized a 451 nm 
NanoLED (HORIBA Jobin Yvon) excitation source and emission monitoring at 520 nm.  
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The Prompt (instrument response) was established by preparing a 1:10 dilution of 
precisely 1 drop (~100 µL) of 34% (w/v) LUDOX (Sigma) into 3 mL MilliQ H2O. 
Excitation Source Repetition Rate was 1 MHz.  Bandpass was 1.1 nm, Alpha Value 
≤2.0%, and Sync Delay 30 ns.  Measurement Range was 200 ns.  The RT Preset was 0 
seconds; the Peak Preset was 10000 counts.  Lifetime determinations were performed 
on 1 µM DBCO488 and on 1 µM uncleaved CtermpaF-DBCO488-surv1-120 in loading 
buffer.  Data were processed using DataStation Analysis Software (HORIBA Jobin 
Yvon). 
  
2.11 Metallation of Diethylenetriaminepentaacetic acid (DTPA) 
Dissolution of 10 mM DTPA in 100 mM MES, pH 5.5, was achieved by incubation 
at 75˚C for 5-10 minutes.  Metallation of DTPA with terbium was achieved by incubating 
40 mM TbCl3 and 10 mM DTPA at 75˚C for 8.25 hours in 100 mM MES, pH 5.5.  
Samples were cooled to room temperature prior to fluorescence analysis using an 
excitation of 350 nm. 
 
1D NMR Analysis of Metallated DTPA 
1D NMR analysis of the following was performed at 298K on a 600 MHz Bruker 
(Billerica, MA) NMR magnet:  
10 mM DTPA in 100 mM ammonium acetate, pH 5.5, containing 10% (v/v) D2O 
40 mM TbCl3 in 100 mM ammonium acetate, pH 5.5, containing 10% (v/v) D2O 
10 mM DTPA, 40 mM TbCl3 in 100 mM ammonium acetate, pH 5.5, containing 
10% (v/v) D2O before and after metallation incubation 
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 Anion Exchange Purification of Metallated DTPA 
Separation of metallated DTPA (hereafter denoted DTPA:Tb) from excess 
terbium trichloride was achieved using anion exchange chromatography.  The 
metallation incubation reaction (4 mL) was filtered through an Acrodisc® 32 mm syringe 
filter with 0.2 µm Supor® non-pyrogenic membrane.  An ÄKTA Purifier 100 / 10 FPLC 
was used in conjunction with a HiTrap Q FF 5 mL (GE Healthcare) anion exchange 
column, equilibrated with at least five column volumes (25 mL) of 100 mM MES, pH 5.5, 
prior to addition of the filtered metallation reaction.  After application of the metallation 
reaction (4 mL), the SuperLoop® injector column was protected from light with 
aluminum foil.  Three column volumes (15 mL) of 100 mM MES, pH 5.5, were applied to 
the HiTrap Q FF anion exchange column, during which time 3.5-mL fractions were 
collected.  Elution of metallated DTPA was achieved using 0-100% loading buffer 
containing 1 M sodium chloride; the gradient was carried out over 8 column volumes 
during which time 3.5-mL fractions were collected.  The Frac-920 carousel fraction 
collector and fraction collection tubes were protected from light with aluminum foil for 
the duration of the purification.   
 
2.12 Amide Coupling to Synthesize Clickable Chelator 
Amide coupling was performed as follows: DTPA:Tb from anion exchange 
chromatography separation was estimated to be 10 mM based on the initial 
concentration of DTPA used in the metallation experiment (10 mM) and the 1D NMR 
data that suggested the reaction went to completion; DBCO-amine in 8.33% (v/v) 
DMSO in 100 mM MES, pH 5.5, was added to achieve a final concentration of 50 mM 
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DBCO-amine.  Amide coupling reagent 1-ethyl-3-(3-dimethylamino-propyl)-carbodiimide 
(EDC) was added to 50 mM to facilitate the amide coupling reaction.  The amide 
coupling reaction was performed at room temperature, protected from light with 
aluminum foil, with gentle rocking, for 120 minutes, prior to applying approximately 1000 
µL of the reaction mix to an equilibrated G10 Sephadex size-exclusion column.    
 
Size-Exclusion Column Chromatography Separation of Amide Coupling 
Reaction 
A 3.5-mL Sephadex G10 column was poured according to manufacturer’s 
specifications (GE Healthcare) into a 10 cm x 1 cm glass Econo-column low-pressure 
chromatography column with a cross-sectional area of 0.79 cm2 with translucent 
polypropylene end fittings (Bio-Rad) and low-pressure tubing (Bio-Rad).  The column 
was shielded from light with aluminum foil.  Separation of the product (the clickable 
chelator (DBCO-DTPA:Tb)) and reactants (DBCO-amine and metallated DTPA 
(DTPA:Tb)) from the amide coupling reaction mix was achieved by addition of 12-14 
column volumes (42 – 49 mL) of 100 mM MES, pH 5.5, during which time approximately 
4 mL fractions were collected, protected from light with aluminum foil, at room 
temperature. 
 
2.13 Fluorescence Anisotropy or Polarization 
Cuvette Fluorometer 
Fluorescence anisotropy experiments were initiated using the Fluoromax4 
Fluoro-Hub.  The experimental setup for preliminary binding assays utilized a 3-mL 
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quartz cuvette, 100 nM fluorescently-labeled histone-3 peptide (H3*) of sequence Ac-
ARTKQTARKS-K(fam)-CONH2, and variable concentration of purified uncleaved or 
thrombin-cleaved Survivin1-120 in 100 mM potassium phosphate, pH 7.5, 100 µg/mL 
bovine gamma globulin (BGG), 0.02% (w/v) sodium azide.  Different maximum 
concentrations of cleaved and uncleaved Survivin were obtained during protein 
purifications of cleaved and uncleaved Survivin.  These different maximum Survivin 
concentrations were used in serial dilutions of Survivin for fluorescence anisotropy 
experiments.  For the experiment evaluating thrombin-cleaved Survivin1-120, the 
following final concentrations (µM) were used: 0, 0.16, 0.36, 0.66, 1.32, 2.63, 5.26, 
10.53, and 21.05.  For the experiment evaluating uncleaved His6-Survivin1-120, the 
following final concentrations (µM) were used: 0, 0.02, 0.04, 0.07, 0.14, 0.28, 0.56, 1.13, 
2.25, 4.5, 9.0, 18.0, and 36.0.  Survivin1-120 and 100 nM H3* (total final volume of 2.5 
mL) were incubated for 30 minutes at 37°C with gentle stirring, protected from light, then 
read at 37°C in a pre-warmed cuvette holder using an excitation of 493 nm monitoring 
emission at 522 nm.  Instrument output was in percent anisotropy (%r) or percent 
polarization (%P).   
 
Plate Fluorometer 
 Determination of Dissociation Constant 
To determine the dissociation constant of carboxyfluorescein-labeled histone-3 
peptide (H3*) for Survivin1-120, a black, flat-bottom 96-well plate (Costar, Corning, 
Tewksbury, MA), 1 µM H3*, and 0 – 152 µM uncleaved Survivin1-120 in 100 mM 
potassium phosphate, pH 7.5, were used.  Samples were analyzed in triplicate.  
47 
 
((IVVsample – IVVblank) – (IVHsample – IVHblank))
((IVVsample – IVVblank) + (IVHsample – IVHblank))
P=
Uncleaved His6-Survivin1-120 and 1 µM H3* (total final volume of 100 µL) were incubated 
for 30 minutes at 37°C, protected from light, with occasional gentle mixing, then read at 
37°C in a pre-warmed BioTek Synergy 2 (BioTek, Winooski, VT) plate reader using 
Gen5 software, version 1.11.5 (BioTek), using the tungsten-halogen lamp.  Excitation 
and emission wavelengths were 485 and 528 nm, respectively.   
For all plate fluorometer experiments, instrument output was in parallel 
fluorescence intensity and perpendicular fluorescence intensity; data were processed 
using Excel.  Fluorescence polarization values (P) (in fluorescence polarization units) 
were determined using the following equation: 
 
 
 
 
Where IVV is the parallel fluorescence intensity (excitation and emission polarizers are 
both oriented vertically) and IVH is the perpendicular fluorescence intensity (excitation 
polarizer is oriented vertically and emission polarizer is oriented horizontally). 
 
Evaluation of Binding Specificity 
To evaluate specificity of the His6-Survivin1-120:H3* binding interaction, unlabeled 
histone 3 (H3) peptide was titrated into wells containing 30 µM His6-Survivin1-120 and 1 
µM H3* in 100 mM potassium phosphate, pH 7.5.  The assay was performed one time 
and included samples in triplicate.  His6-Survivin1-120 and H3* (total final volume of 100 
µL) were incubated for 30 minutes at 37°C, with occasional gentle mixing, then read at 
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37°C in a pre-warmed plate reader.  Then, unlabeled histone-3 peptide was added to 
each well and the plate incubated at 37°C for 5 minutes, after which time the plate was 
read.  Excitation and emission wavelengths were 485 and 528 nm, respectively. 
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Chapter 3: Utility of Copper-Free Click Chemistry to Site-Specifically 
Fluorescently Label the Survivin Protein for Protein-Protein Interaction Studies 
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3.1 Introduction  
Steady-state fluorescence intensity measurements, FRET, and fluorescence 
lifetime have been successfully used to evaluate protein dynamics [Beechem and 
Brand, 1985, Lim, et al., 1995, Kuppens, et al., 2003, Poupart, et al., 2006, Hou, et al., 
2007, Serrano, et al., 2012, Lemos and Hungerford, 2013]. Information about the 
fluorophore environment such as changes in viscosity, polarity, pH, and/or solvation, 
shape and size of molecules examined, and molecular interactions may be gleaned 
from fluorescence lifetime determination [reviewed in Berezin and Achilefu, 2010].  
Although fluorescence analyses may be performed using endogenous tryptophans in 
the protein of interest [Allen and McLendon, 2006], site-specific introduction of an 
exogenous fluorophore into the protein of interest may be preferable in many cases.  
Site-specific incorporation confers the ability to probe a specific region of the protein of 
interest where a tryptophan may not exist.  In addition, relative to endogenous 
fluorophores, the exogenous fluorophore may exhibit excitation and emission 
wavelengths disparate from many naturally-occurring fluorophores, allowing for 
selective monitoring of the fluorescence signal.  Typically, exogenous fluorophores have 
a higher quantum yield, a higher molar extinction coefficient, a broader Stokes shift, 
narrower emission bands (narrow full-width at half maximum emission peak), and longer 
fluorescence lifetimes.  Fluorescein and the lanthanide terbium are examples of 
fluorophores that meet many of these criteria [Brannon and Magde, 1978, Ge, et al., 
2004, Rajapaske, et al., 2009], making them ideal probes for evaluating in vitro protein-
protein interactions.   
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Survivin binds one of its partners, histone-3, via the involvement of specific 
amino acids within Survivin’s baculoviral IAP repeat (BIR) domain [Jeyaprakash, et al., 
2011].  Because the structure of the Survivin-histone-3 complex has been solved 
[Jeyaprakash, et al., 2011], Survivin was chosen to provide proof-of-concept for the 
fluorescence-based analyses described herein.  Consequently, we hypothesized that 
site-specific labeling of the Survivin protein with a fluorescent tag may be accomplished 
using copper-free click chemistry and unnatural amino acid incorporation.  The aim, 
thus, was to evaluate the utility of click chemistry to site-specifically label the Survivin 
protein with a fluorophore using copper-free click chemistry in order to monitor protein-
protein interactions of Survivin with its protein binding partners by steady-state 
fluorescence, FRET, and fluorescence lifetime analysis.  Specifically, a FRET pair 
amenable to these analyses is proposed in a subsequent section.  
 
3.2 Results and Discussion 
Rationale for Selecting Positions for Para-azidophenylalanine Insertion 
In order to glean information about specific amino acids involved in a particular 
protein-protein interaction, the specific placement of the fluorophore within the protein of 
interest should be considered.  An additional factor is physical accessibility of the 
introduced unnatural amino acid (paF) with regard to the click chemistry reaction to 
introduce the fluorophore.  The impact of the paF and the azide on secondary and 
tertiary structure(s) of the protein should be considered as well.  To try to address each 
of these considerations, several mutants were made.  In two separate mutants, 
phenylalanines at positions 93 and 101 were mutated to paF as conservative amino 
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acid substitutions to evaluate the impact of the azide on Survivin protein structure, 
function, and partner binding interactions.  In three separate mutants, tryptophans in 
positions 10 and 67 and glycine in position 99 were mutated to paF due to the fact that 
amino acids 10, 67, and 99 reside within suvivin’s baculoviral IAP repeat (BIR) domain, 
which is involved in binding protein partners along Survivin’s apoptotic and mitotic 
pathways.  Finally, paF was inserted at Survivin’s extreme N- (position 0) and C-termini 
(position 121), in two separate mutants, to evaluate the consequences of paF insertion 
at locations disparate from Survivin’s BIR domain.  Click chemistry-mediated 
incorporation of a fluorophore with paF in each of these positions confers the 
opportunity to obtain information about Survivin protein binding interactions relative to 
each of these positions. 
 
Para-azidophenylalanine-containing Survivin1-120 Protein Purification  
All seven mutant Survivin plasmid sequences encoding the amber stop codon 
where paF was inserted were correct.  As shown in Figure 3.1, western blotting of all 
seven paF-containing Survivin1-120 mutants yielded band density at the molecular weight 
corresponding to the Survivin1-120 dimer.  The N-terminal paF-containing Survivin mutant 
was selected for initial copper-free click chemistry with DBCO488. 
 
Copper-free Click Chemistry Reactions with Small Molecules 
To analyze HPLC separation of the triazole-containing cycloadducted click 
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Figure 3.1: Western blot of paF-containing His6-Survivin1-120 mutant proteins W10paF, 
W67paF, F93paF, F101paF, G99paF, NtermpaF, and CtermpaF(dimers ~32 kD, 
monomers at ~16 kD), with Survivin1-120 control. 
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chemistry product, an HPLC method for a triazole-containing small molecule 
ketoconazole (data not shown), was employed.  Subsequently, the small molecules paF 
and DBCO488 were individually evaluated by HPLC.  The small molecule paF was used 
in preliminary attempts at performing copper-free click chemistry with DBCO488 prior to 
utilizing paF-containing Survivin1-120 protein, due to the limited availability of the latter.  
The copper-free click chemistry reactions using small molecules paF and DBCO488, 
described in the Materials and Methods chapter, were evaluated by HPLC. As shown in 
Figure 3.2, 100 mM paF in 80% (v/v) acetic acid exhibited absorbance at 280 and 310 
nm and eluted from the column at precisely 4 minutes.  As shown in Figure 3.3, 354 µM 
DBCO488 in 100% DMSO exhibited absorbance at 454 nm and eluted at 7 minutes 
(Figure 3.4).  These results established the absorbance maxima that correlated with 
paF and DBCO488, which were subsequently used as a starting point for analyzing 
small molecule click chemistry reaction success by HPLC. As shown in Figures 3.5, 3.6, 
and 3.7, HPLC analysis of the 1:1, 10:1, and 1:10 alkyne:azide copper-free click 
chemistry reactions, respectively, yielded the following: paF generated a peak at the 
expected retention time (4 minutes) and with absorbance at 280 and 310 nm.  
DBCO488 generated a peak at the expected retention time (7 minutes) and with 
absorbance at 454 nm.  The paF-DBCO488 cycloadducted product generated a single 
peak that exhibited absorbance of paF and DBCO488 (280, 310, and 454 nm).  In other 
words, a single peak in the HPLC spectrum exhibited absorbance at the same unique 
wavelengths of paF and DBCO488 (280, 310, and 454 nm).  This suggested that the 
new peak contains paF, which absorbs at 280 and 310 nm, and DBCO488, which 
absorbs at 454 nm.  In addition, the paF-DBCO488 cyclo- 
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Figure 3.2: HPLC separation of 50 µL of 100 mM para-azidophenylalanine (paF) in 80% 
(v/v) acetic acid.  Absorbance (milli Absorbance Units (mAU)) is depicted on the left y-
axis, retention time (minutes) on the x-axis, and %B (light gray trace) on the right y-axis. 
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454 nm
Blank
DBCO488
  
Figure 3.3: Absorbance scan of 50 µL of 354 µM DBCO488 (DBCO488 trace) in 100% 
DMSO relative to DMSO (Blank trace).  Absorbance (Abs) is on the y-axis and 
wavelength (nm) on the x-axis. 
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Figure 3.4: HPLC separation of 50 µL of 1 mM DBCO488 in 100% DMSO.  Absorbance 
(mAU) is depicted on the left y-axis, retention time (minutes) on the x-axis, and %B 
(light gray trace) on the right y-axis.  Absorbance was monitored at 454 nm. 
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adducted product eluted at 6 minutes, as shown in Figures 3.5, 3.6, and 3.7 for the 1:1 
alkyne:azide, 10:1 alkyne:azide, and 1:10 alkyne:azide reactions, respectively.  This 
unique retention time of the paF-DBCO488 is expected as the addition of the paF to the 
DBCO488 makes DBCO488 slightly more hydrophilic.  The unique retention times and 
absorbance character of the reactants and products suggested that these molar 
stoichiometries generated the desired paF-DBCO488 cycloadduct.  Interestingly, the 
presence of two DBCO488 peaks in Figure 3.6 may suggest that stereoisomers of 
DBCO488 are present.  Multiple DBCO488 conformers may be present that exhibit 
differential retention on the C18 column matrix.  This suggestion is corroborated by 
evaluating the rendering of the chemical structure provided by the DBCO488 supplier 
(Click Chemistry Tools), where the representation of the covalent bond joining the 
amide bond to the fluorescein moiety is drawn to the center of the phenyl ring, not to 
one specific carbon on the phenyl ring.  Interestingly, under conditions of excess alkyne, 
the copper-free click chemistry reaction appears to yield two product peaks (Figure 3.6, 
at 6.05 and 6.2 minutes), which may suggest that the parent conformers are equally 
able to react with paF when excess alkyne is present.  Notably, the mass of alkyne was 
kept constant in all reactions, using variable azide to yield the different molar 
stoichiometries tested. 
To confirm the identity of the HPLC peaks that correspond to the cycloadducted 
product paF-DBCO488, small molecule mass spectrometry of the putative paF-
DBCO488 cycloadducted product from the HPLC-mediated separation of the 1:1 
alkyne:azide click chemistry reaction (fraction 6 minutes) was performed.  As shown in 
Figure 3.8, mass spectrometry analysis of an aliquot of the 6-minute HPLC fraction 
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showed a single, sharp peak that corresponded to the theoretical mass of the 
cycloadduct, 841.26 Da.   
Collectively, these results suggest that the copper-free click chemistry reactions 
were successful using the small molecules paF and DBCO488.  Thus, the next step 
was to attempt copper-free click chemistry with the azide-containing protein 
NtermpaFsurv1-120 and the fluorescent cyclooctyne, DBCO488.  
 
Copper-free Click Chemistry Reaction with Azide-containing Survivin1-120 
As was shown in Figure 3.3, 354 µM DBCO488 in 100% DMSO yielded an 
absorbance maximum of 454 nm.  As shown in Figure 3.9, however, DBCO488 bound 
to NtermpaFSurvivin1-120 exhibited an absorbance maximum of 500.5 nm.  This shift is 
due to solvatochromism, i.e. the property of a compound’s change in absorbance 
character depending on the solvent in which it is dissolved. Therefore, size exclusion 
analyses monitored absorbance at 280 and 500 nm.  
As shown in Figure 3.10, size-exclusion chromatography results indicated that 
NtermpaF-DBCO488-Survivin1-120 size exclusion chromatography fractions possessed 
dual absorbance at 280 nm and 500 nm.  This result suggested that the protein and 
fluorophore co-eluted.  Because unbound DBCO488 would have eluted much later in 
the size exclusion column compared to protein, due to its small size when unbound to 
protein, the FPLC A280 and A500 traces’ overlap suggests that Survivin1-120 protein and 
DBCO488 bound each other.  This suggested that the copper-free click chemistry 
reaction between DBCO488 and paF-containing Survivin1-120 was successful.  Thus, the 
next step was to separate select fractions by SDS-PAGE, then analyze them by UV ill- 
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Figure 3.5: HPLC separation of 50 µL of 1:1 alkyne:azide copper-free click chemistry 
reaction of reactants para-azidophenylalanine (paF) and DBCO488 in loading buffer, 
and product, paF-DBCO488.  Absorbance (mAU) is depicted on the left y-axis, retention 
time (minutes) on the x-axis, and %B (light gray trace) on the right y-axis. 
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Figure 3.6: HPLC separation of 50 µL of 10:1 alkyne:azide copper-free click chemistry 
reaction of reactants para-azidophenylalanine (paF) and DBCO488 in loading buffer, 
and product, paF-DBCO488.  Absorbance (mAU) is depicted on the left y-axis, retention 
time (minutes) on the x-axis, and %B (light gray trace) on the right y-axis. 
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Figure 3.7: HPLC separation of 50 µL of 1:10 alkyne:azide copper-free click chemistry 
reaction of reactants para-azidophenylalanine (paF) and DBCO488 in loading buffer, 
and product, paF-DBCO488.  Absorbance (mAU) is depicted on the left y-axis, retention 
time (minutes) on the x-axis, and %B (light gray trace) on the right y-axis. 
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Figure 3.8: TOF electrospray mass spectrometry in positive ion mode detection of 
cycloadducted product, paF-DBCO488, inset, of the copper-free click chemistry reaction 
of para-azidophenylalanine and DBCO488.  Expected monoisotopic mass: 840.26 Da.  
The y-axis depicts the percent relative abundance; the x-axis depicts the retention time 
in minutes. 
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Figure 3.9: Absorbance scan of NtermpaF-DBCO488-Survivin1-120 (DBCO488 trace) in 
loading buffer (Blank trace).  Absorbance (Abs) is on the y-axis and wavelength (nm) on 
the x-axis. 
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Figure 3.10: Chromatograph of NtermpaF-DBCO488-Survivin1-120 separated by HiLoad 
26/60 Superdex 200 preparative-grade size-exclusion column.  The y-axis depicts 
absorbance (mAU) and the x-axis indicates the volume (mL) of mobile phase passed 
over the column.  The 280, 500, and 310 nm traces are as indicated. 
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Figure 3.11: A: Fluorescence of SDS-PAGE-resolved fractions containing NtermpaF-
DBCO488-Survivin1-120 (denoted *Survivin1-120) or Survivin1-120.  B: Western blot of SDS-
PAGE-resolved NtermpaF-DBCO488-Survivin1-120 with and without paF (denoted +paF 
and –paF, respectively) included in the overexpression medium, or Survivin1-120.  C: 
Coomassie stained gel of SDS-PAGE-resolved NtermpaF-DBCO488-Survivin1-120 
(denoted *Survivin1-120) or Survivin1-120.  
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umination, Coomassie staining, and western blotting to evaluate click chemistry reaction 
success. 
As shown in Figure 3.11A, SDS-PAGE separation followed by UV gel illumination 
to monitor fluorescence revealed discrete fluorescent bands.  This suggested that 
DBCO488 had been specifically incorporated into a protein that can oligomerize; 
Survivin1-120 molecular weights are 15 kD (monomer), ~30 kD (dimer), and ~45 kD 
(trimer).  Therefore, the fluorescence result suggests that DBCO488 bound a protein 
that exhibited nearly identical molecular weights of Survivin1-120 monomer, dimer, and 
trimer. 
As shown in Figure 3.11B, western blot analysis of Survivin1-120 yielded 
substantial band density at 15 kD in the +paF and Survivin1-120 lanes.  In the wild type 
Survivin1-120 control (Figure 3.11B), band density is evident at ~15 and ~30 kD, 
corresponding to Survivin monomer and dimer, respectively.  Band density that would 
correspond to Survivin trimer (~45 kD) is not present in the Survivin1-120 control.  These 
results suggest that Survivin1-120 does not adopt a trimeric association or that the 
conformational antibody does not recognize and bind Survivin in its trimeric 
conformation.  These results may also mean that the modification yields a trimeric 
aggregate, in addition to the monomer and dimer.  The immunogen used for Survivin 
antibody generation is a synthetic peptide that corresponds to the amino terminal of the 
Survivin protein (Cell Signaling product information, catalog number 2802S).  Our 
results suggest that this antibody can recognize and bind the N-terminus of Survivin1-120 
when it adopts both its monomeric and dimeric conformations.  A Coomassie stain of 
pure Survivin1-120 indicated the presence of protein at ~15 kD (Figure 5.1); a Coomassie 
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stain and western blotting of pure DBCO-labeled NtermpaFSurvivin1-120 could be used to 
determine the presence of dimeric and/or trimeric Survivin1-120 or contaminants. 
As shown in Figure 3.11 panels A and B, the western blot band density at 15 kD 
in the +paF lane overlaps the fluorescent band near 15 kD in the NtermpaF-DBCO488-
Survivin1-120 lane.  This suggests that the fluorescence at 15 kD corresponds to 
fluorophore incorporation into Survivin1-120.  The presence of multiple fluorescent bands 
in the NtermpaF-DBCO488-Survivin1-120 lanes suggest that the fluorophore was 
incorporated into protein that is present at ~15, ~30, and ~45 kD.  Interestingly, 
however, band density in the western blot +paF lane is only present at ~15 kD.  That 
very faint band density in the NtermpaF-DBCO488-Survivin1-120 lane was detected at 
~30 and virtually none was detected at ~45 kD by western blotting suggests that protein 
is present at these positions.  Given that the antibody recognizes the amino terminal of 
Survivin, it is possible that the fluorophore at the extreme N-terminus of the protein may 
interfere with antibody recognition and binding of the dimeric conformation of the 
NtermpaF-DBCO488-Survivin1-120 construct.  Although highly unlikely, an alternative 
possibility is that the protein present at ~30 and ~45 kD by fluorescence is not Survivin. 
As shown in Figure 3.11 panel C, Coomassie-staining of these same samples 
yields many bands, which suggest that the preparation is quite impure. While this is 
undesirable regarding sample purity and further purification was necessary (and 
subsequently achieved (Figure 3.12)), this is still a promising result when the 
fluorescence and Coomassie outcomes are considered simultaneously.  The 
Coomassie result suggests that many proteins are present within the lane.  The 
fluorescence result, however, indicates that fluorescence is only associated with three 
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discrete bands.  This result suggests that only some of the proteins present in the lane 
impart a signal by fluorescence.  The conclusion based on this result is that the 
fluorophore was specifically incorporated into only some proteins in the lane.  If the 
fluorophore was non-specifically incorporated into all of the proteins present in the lane, 
as indicated by the Coomassie, then the fluorescence signal would also have been 
smeared and would have correlated with the entire height of the lane.  Taken together, 
we believe that these results demonstrate the ability to introduce a fluorophore site-
specifically into the protein of interest using click chemistry.  
To address BL21*DE3 E. coli expressing the unnatural amino acyl tRNA 
synthetase to insert arginine at the amber stop codon, over-expression, purification, and 
western blot analysis of the –paF negative control was performed.  Western blot 
analysis (Figure 3.11B) revealed a faint band at ~15 kD, which suggested that only a 
small fraction of Survivin translation resulted in putative arginine incorporation at the 
amber stop codon.  A repeat of this analysis with optimal concentrations of loaded 
protein would clarify whether or not the faint band in the –paF lane was inadvertent 
contamination from the neighboring Survivin1-120 control lane. 
After we demonstrated the ability to fluorescently label the N-terminal paF-
containing Survivin1-120 protein, we subsequently performed copper-free click chemistry 
on the C-terminal paF-containing Survivin1-120 protein.  The labeled Survivin protein was 
purified using size-exclusion chromatography, as shown in Figure 3.12.  Distinct band 
density is evident at 15 kD, the expected size of uncleaved Survivin1-120 protein.  The C-
terminally-labeled protein did not appear to aggregate, as suggested by the presence of 
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a single band at 15 kD.  This purified protein was utilized in the fluorescence lifetime 
determination. 
 
DBCO488-labeled Survivin1-120  Excitation and Emission Maxima 
Survivin1-120 with the DBCO488 fluorophore adducted to the extreme C-terminus 
(CtermpaF-DBCO488-Survivin1-120) (1 µM) yielded an emission maximum of 520 nm 
using the Nano-LED excitation wavelength of 451 nm in 50 mM Tris, pH 7.46 at 22˚C, 
500 mM sodium chloride, 2 mM β-mercaptoethanol.  Emission was monitored at 520 nm 
for the time-correlated single photon counting (TCSPC) analyses. 
 
TCSPC Analyses of Fluorescently-Labeled Survivin Protein 
The pKa of the fluorescent moiety of DBCO488, fluorescein, is 6.4, so at pH 
7.01, the pH of this experiment, fluorescein fluctuates between neutral and negatively-
charged, unprotonated, species.  As shown in Figure 3.13, time-correlated single-
photon counting analysis of 1 µM CtermpaF-DBCO488-Survivin1-120 in 50 mM Tris, pH 
7.01 at 37˚C, 500 mM sodium chloride, 2 mM β-mercaptoethanol yielded a single-
exponent decay curve, random residuals, and an acceptable chi-squared <1.2, of 1.078.  
The calculated fluorescence lifetimes equaled 1.39 and 4.03 ns, which exactly 
recapitulated literature precedent for unprotonated fluorescein [Magde, et al., 1999].  
These data suggested that DBCO488-labeled at the C-terminus of Survivin1-120 protein 
exhibited the expected fluorescein fluorescence lifetimes. 
 
3.3 Conclusions 
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Figure 3.12: SDS-PAGE followed by Coomassie analysis of purified uncleaved 
CtermpaF-DBCO488-Survivin1-120. 
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Figure 3.13: Time-correlated single photon counting data of 1 µM CtermpaF-DBCO488-
Survivin1-120 (Experimental sample trace – red dots with green curve) in 50 mM Tris, pH 
7.01 at 37˚C, 500 mM sodium chloride, 2 mM β-mercaptoethanol, compared to the 
instrument response (Prompt trace – blue dots) to determine fluorescence lifetime of 
DBCO488-labeled Survivin1-120 protein.  The residuals plot (green trace) is depicted 
below.  Counts: counts per second of emitted photons.  Channels: 0.055 ns/channel.   
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Utility of Copper-Free Click Chemistry In Vitro 
The objective of these analyses was to site-specifically label Survivin1-120 with a 
fluorophore using click chemistry for analysis of protein-protein interactions.  Data 
obtained using HPLC and MS suggested that copper-free click chemistry reactions 
between small molecules paF and DBCO488 are promising, thereby providing 
precedent that the reaction might also work with azide-containing Survivin and other 
proteins.  Data obtained using Coomassie, western blot, fluorescence, and size 
exclusion chromatography suggested that the copper-free click chemistry reaction 
between DBCO488 and paF-containing Survivin1-120 was successful.  This suggested 
that further examination of the fluorescently-labeled Survivin1-120 protein, including 
characterizing the steady-state fluorescence and determining the fluorescence lifetime, 
was merited.  The results obtained supported the hypothesis that copper-free click 
chemistry may be used to site-specifically label azide-containing target proteins with 
fluorophores. 
Because of the sensitivity and versatility of the fluorescence-based approaches, 
including steady-state fluorescence intensity, FRET, and fluorescence lifetime analysis, 
improved technologies are needed to fully harness the utility of these methods.  
Endogenous fluorophores such as tryptophan may be used in certain fluorescence 
analyses, but advantages may be conferred by using exogenous fluorophores. Relative 
to tryptophan, the common fluorophore fluorescein exhibits a higher quantum yield, 
higher molar extinction coefficient, and excitation and emission maxima disparate from 
endogenous fluorophores.  The lanthanide terbium also possesses some of these 
optimal fluorescence characteristics, in addition to a much longer fluorescence lifetime.  
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For these reasons, exogenous fluorophores have gained appeal for performing steady-
state fluorescence intensity, FRET, and fluorescence lifetime analysis in studying 
proteins and protein-protein interactions.  Importantly, it may not be possible to 
incorporate exogenous fluorophores using the protein target’s endogenous cysteines.  
Therefore, an alternative approach using copper-free click chemistry may be utilized to 
site-specifically incorporate an exogenous fluorophore. 
Site-directed mutagenesis, click chemistry, and fluorescence techniques, used 
together, provide the ability to investigate the consequences of partner binding on a 
specific region of the protein of interest.  The ability to site-specifically introduce a 
fluorescent label into a protein of interest offers the possibility of identifying specific 
amino acids that are germane to a particular protein-protein interaction.  Click chemistry 
enables the introduction of these probes that can be monitored while a binding partner 
is titrated.  Steady-state fluorescence, FRET, and fluorescence lifetime analyses can 
provide insight into the consequences of partner binding, however, because the local 
environmental factors can impact fluorescence intensity, emission maxima, and 
fluorescence lifetime, data should be interpreted accordingly.  These environmental 
factors are described in the following sections. 
 
Utility of Steady-State Fluorescence Intensity Determination to Study 
Protein-Protein Interactions 
Steady-state fluorescence intensity is a quantitative output that yields information 
about the fluorophore environment.  Factors that can affect fluorescence intensity 
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include solvent quenching, buffer constituents, fluorophore concentration, and 
shielding/obstruction by protein partner binding.   
In the context of analyzing the consequences of protein partner binding, steady-
state fluorescence intensity can give information about protein folding and the degree to 
which a protein is in an unfolded or folded conformation.  When tryptophan is buried 
within a protein, tryptophan exhibits an emission maximum at 330 nm [reviewed in 
Ghisaidoobe and Chung, 2014].   When tryptophan is accessible to solvent, the 
emission is shifted to 340 – 350 nm [reviewed in Ghisaidoobe and Chung, 2014].  
Endogenous tryptophan fluorescence intensity may be quenched in an unfolded protein, 
but may increase as the protein folds, shielding tryptophans from solvent quenching, 
however, the polarity of the solvent may alter this trend [reviewed in Ghisaidoobe and 
Chung, 2014].   Additional considerations concern the quantum yield, as follows. 
The efficiency with which a molecule absorbs then emits a photon, the quantum 
yield (Ф), is expressed as the percent of emitted photons divided by the total number of 
absorbed photons [reviewed in Lakowicz, 1999].  Fluorescence quenching results from 
non-radiative decay of the energy of the photon to the system, thereby decreasing 
fluorescence intensity [reviewed in Lakowicz, 1999], a phenomenon called “collisional 
quenching”.  Sources of collisional quenching include interactions of the emitted photon 
with the solvent or with a neighboring small molecule or protein within the experimental 
system.  Quenching may be affected by choosing a different solvent [reviewed in 
Lakowicz, 1999].  Photobleaching, or photochemical destruction of the fluorophore, may 
be reduced by decreasing the time that the sample is exposed to the incident beam 
[reviewed in Lakowicz, 1999].  The fluorophore concentration may be increased to 
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compensate for photobleaching [reviewed in Lakowicz, 1999].  Another strategy is to 
reduce the frequency (and thus the photon energy) of the incident beam [reviewed in 
Lakowicz, 1999].  Finally, robust fluorophores less susceptible to photobleaching may 
also be utilized [reviewed in Lakowicz, 1999]. 
  
Utility of Fluorescence Lifetime Analyses for Monitoring Protein-Protein 
Interactions 
Fluorescein is one of the fluorescent moieties comprising the DBCO488 
molecule.  Fluorescein and other fluorophores may exhibit different fluorescence 
lifetimes based on protonation state [Martin and Lindqvist, 1975, Magde, 1999].  
Fluorescein’s pKa is 6.4 and when protonated, fluorescein exhibits a fluorescence 
lifetime of 3 ns; unprotonated, the fluorescence lifetime is 4 ns [Magde, 1999].  
Fluorescein fluorescence lifetime has therefore been used as a pH indicator [Hammer, 
et al., 2005].  In addition to protonation state, changes in solvent shielding may alter 
fluorescence lifetime.  Static and dynamic fluorescence quenching can decrease 
fluorescence lifetime because the fluorophore is prevented from achieving its excited 
state or returns to its lower energy state more readily than when quenching does not 
occur [Alcala, et al., 1987], respectively.  If the fluorophore is shielded from quenching, 
the fluorescence lifetime may be longer than if the fluorophore is accessible to the 
quenching solvent [Alcala, et al., 1987].  Fluorophore shielding may result from protein 
partner binding near the fluorophore.  Therefore, changes in fluorophore lifetime can 
provide insights into protein partner binding.  Importantly, if the purpose of the 
experiment is to obtain information about the protein binding interface, the location of 
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the fluorophore within the protein of interest should be known, i.e., site-specific.  
Survivin binds many partners including caspase-9 to inhibit apoptosis.  Inhibiting 
Survivin binding to caspase-9 may facilitate cancer cell apoptosis.  Identifying druggable 
binding interfaces of the Survivin-caspase-9 interaction may be achieved using the 
fluorescence-based approaches described herein.  Subsequently, the portion of the 
labeled Survivin found to interact with caspase-9 could be mimicked with a synthetic 
peptide and implemented in a high-throughput fluorescence polarization screening 
assay (chapters 1 and 5) to identify candidate small molecule inhibitors of the Survivin-
caspase-9 protein-protein interaction. 
Although the DBCO488-labeled Survivin1-120 construct recapitulated literature 
precedent for unprotonated fluorescein fluorescence lifetime (4.03 ns), the only 
conclusion that can be drawn from this single experiment is that the fluorescein moiety 
behaves, in this context, like free, unprotonated fluorescein with regard to fluorescence 
lifetime.  There are limitations to the interpretation of fluorescence lifetimes.  Although 
fluorescence lifetime can yield protein conformation information, lifetime measurements, 
alone, may provide only limited information given the complexity of the experimental 
setup and output interpretation.  A series of experiments are required for proper 
interpretation of the observed fluorescence lifetime.  In the context of fluorescein-
labeled Survivin1-120 binding histone-3, several interpretations may be possible.  Mixed 
populations of 3.0 and 4.0 ns lifetimes may be observed as a result of solvent 
accessibility or shielding.  Mixed populations may also arise because the side chain of 
histidine exhibits a pKa of 6.0, which is near that of fluorescein.  It is possible that 
protons may be exchanged between the fluorescein moiety of DBCO488 and Survivin’s 
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histidine 80.  Because a single fluorescence lifetime output has multiple interpretations, 
lifetime data interpretations are usually made in concert with outputs from other 
fluorescence-based approaches.  Steady-state fluorescence intensity, for example, 
gives information on the quantity of photons emitted and FRET analyses give 
information about donor-acceptor distance.  Consequently, in order to fully appreciate 
the consequences of titrating protein binding partner into protein of interest, the three 
methods together yield the most comprehensive information about the fluorophore 
environment. 
   
 Fluorophore Limitations 
   Fluorescein 
Fluorescence lifetime measurements, in tandem with additional 
fluorescence-based experiments, have been proposed to evaluate protein-protein 
interactions.  The fluorophore utilized in this chapter (dibenzylcyclooctyne-488, Click 
Chemistry Tools) was a fluorescein derivative amenable to copper-free click chemistry-
mediated incorporation into the protein of interest.  DBCO488 was also chosen because 
it is relatively small and lacks a long, flexible linker region between the DBCO- moiety 
and the fluorescein moiety.  Fluorescein has been widely used for fluorescence 
analyses because it elicits a quantum yield near unity, 94% [Brannon and Magde, 
1978].  It also can yield two different fluorescence lifetimes depending on whether or not 
the carboxylic acid is protonated  and has found utility as a pH indicator [Magde, et al., 
1999].  In the context of pH determination, that fluorescein exhibits different lifetimes 
based on protonation state is a benefit.  In the context of protein-protein interactions, 
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that fluorescein can exhibit multiple lifetimes based on protonation state may confound 
data interpretation.  Therefore, it is important to consider the sources of protonation 
state changes in experimental design and to interpret the data accordingly. 
 
   DBCO-Containing Fluorophores for TCSPC Analyses 
   A variety of commercially-available DBCO-containing fluorophores 
exist that may be site-specifically incorporated into the protein of interest including 
DBCO-carboxyrhodamine, DBCO-sulforhodamine, DBCO-Cy3, DBCO-Cy5, and DBCO-
Cy7 (Click Chemistry Tools).  Currently, however, there is a dearth of clickable 
fluorophores amenable to our analyses because we possess the 293, 335, and 451 nm 
Nano-LEDs, which is a specialized incident beam for performing time-correlated single-
photon counting fluorescence lifetime determinations.  DBCO-rhodamine has an 
excitation profile that overlaps 451 nm, however, 451 nm excitation would elicit only 
about 25% of the fluorescence intensity compared to maximal excitation wavelength.  In 
addition, the long, flexible linker region between the DBCO- moiety and the fluorophore 
may stymie data interpretation regarding the fluorophore environment and effects of 
solvent quenching, as it may rotate more freely in solution than a fluorophore devoid of 
a long, flexible linker. 
With few exceptions, the emitted photon exits the molecule with a 
unique, specific, and unchanging emission wavelength [Kasha, 1950].  That a molecule 
elicits a consistent emission profile may be beneficial for monitoring that molecule 
during processes such as chemical synthesis or in cases where excitation of an 
exogenous fluorophore overlaps that of an endogenous fluorophore, but the 
80 
 
fluorophores exhibit different emission maxima.   Therefore, one possible alternative to 
the commercially-available DBCO-containing fluorophores may be to utilize the 
fluorescence character of the dibenzylcyclooctyne moiety (described in more detail in 
chapter 4).  Briefly, upon excitation at 259 nm, DBCO-amine yielded a unique 
fluorescence emission with a peak at 383 nm as well as a broad emission band at 740 
nm.  It is possible that emission at 740 nm of this inflexible fluorescent moiety could be 
monitored in fluorescence lifetime determinations. 
 
Solvatochromism 
Solvatochromism, or a shift in a molecule’s absorbance maximum based 
on solvent polarity, should be considered when moving from control stock solution 
analysis to in situ analyses.  DBCO488 exhibited an absorbance maximum of 454 nm in 
100% DMSO and 500.5 nm when adducted to the Survivin1-120 protein in 50 mM Tris, 
pH 8.0, 500 mM sodium chloride, 2 mM β-mercaptoethanol.  This bathochromic shift, a 
shift to a longer wavelength with increasing solvent polarity (positive solvatochromism), 
may occur with other fluorophores that may be utilized for the studies described in this 
chapter.  Negative solvatochromism (hypsochromism), or a shift to a shorter wavelength 
with increasing solvent polarity, is also possible.   In some cases, maxima may shift 
several hundred nanometers [Brooker, et al., 1951, Morley, et al., 1997].  Therefore, it 
may be necessary to determine the absorbance maxima of the fluorophore in different 
solvent contexts to ascertain that the analytical conditions are most reflective of the 
experimental conditions. 
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Proposed Approach to Utilize Endogenous Tryptophan Fluorescence 
in FRET with the Lanthanide Terbium 
The lanthanide terbium has a moderate extinction coefficient but imparts 
substantial fluorescence emission intensity at wavelengths separate from endogenous 
fluorophores.  Interestingly, terbium excitation maximum is 350 nm, which is near the 
emission maximum of tryptophan.  One possible FRET experiment would include 
exciting the endogenous tryptophan in the target protein in the presence of terbium-
labeled partner. 
   
In summary, using site-directed mutagenesis coupled with copper-free click 
chemistry, we have demonstrated the ability to insert a fluorescent tag into the Survivin1-
120 protein and purify the labeled protein.  We recapitulated literature precedent 
regarding unprotonated fluorescein fluorescence lifetime in labeled Survivin1-120 protein.  
These approaches poise us for performing fluorescence analyses on Survivin1-120 with 
Survivin’s binding partners.   
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Chapter 4: Two-Step Aqueous Synthesis of a Clickable Lanthanide Chelator 
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4.1 Introduction 
Lanthanides, rare earth metal elements, are novel tools for fluorescence-based 
[Nitz, et al., 2004, Hagan and Zuchner, 2011], x-ray crystallographic [Hiruma, et al., 
2013], and NMR [Su, et al., 2006, Otting, 2008, Hiruma, et al., 2013] applications.  
Lanthanides have broad Stokes shifts [Horrocks, 1993], long fluorescence lifetimes 
[Hemmila, 2005], narrow emission bands (narrow full-width at half maximum (FWHM)) 
[Lakowicz, 1999], are relatively insensitive to photobleaching [Pandya, 2006], and have 
excitation and emission maxima disparate from tryptophan, phenylalanine, and tyrosine 
[Brittain, et al., 1976, Horrocks, 1993].  In the context of x-ray crystallography, 
lanthanides are used for anomalous dispersion experiments [Purdy, et al., 2002].  
Lanthanides’ unique paramagnetic properties may be utilized in NMR applications 
[Iwahara and Clore, 2006, Clore and Iwahara, 2009, Madl, et al., 2009].  These 
approaches can be used to evaluate protein dynamics and protein-peptide interactions, 
but incorporation of a suitable lanthanide chelator is required to fully harness 
lanthanides’ unique properties. 
Numerous strategies for the incorporation of lanthanide chelators have been 
employed including genetic or thiol-reactive insertion [Franz, et al., 2003, Hiruma, et al., 
2013] of a lanthanide binding tag (LBT) [Nitz, et al., 2004].  The LBT’s cumbersome size 
may interfere with proper folding of the target protein, prompting efforts to pursue small 
molecule lanthanide chelators.  Small molecule lanthanide chelators such as 
ethylenediaminetetraacetic acid (EDTA) and its derivatives 1,4,7,10-tetraazacyclo-
dodecane-1,4,7,10-tetraacetic acid (DOTA) and diethylenetriaminepentaacetic acid 
(DTPA) exhibit attomolar lanthanide binding affinity [Cacheris, et al., 1987] and have 
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been used for decades for their superior luminescence intensities [Brittain, et al., 1976, 
Horrocks, 1993] and, more recently, for NMR experiments [Almeida, et al., 2011].  
These small molecule lanthanide chelators and their analogs have been derived to react 
with a protein’s available cysteines [Su, et al., 2008, Häussinger, et al., 2009, Almeida, 
et al., 2011, Zhang, et al., 2011].  Where only one reactive cysteine is present, this can 
generate peak shifts of substantial magnitude and facilitate deconvolution of NMR 
spectra to yield structural information [Otting, 2008].  In most cases, however, the 
protein of interest contains multiple cysteines and/or they are critically involved in 
disulfide bond formation or other secondary structure stabilizing events, thereby 
precluding site-directed mutagenesis-mediated insertion or substitution of cysteine for 
site-specific insertion of a lanthanide chelator.  
Synthesis of small-molecule lanthanide chelators has been demonstrated, 
however, the syntheses published to date require numerous steps, are performed under 
organic, not aqueous conditions, and yield chelators that are thiol-reactive [Saha, et al., 
1993, Ge and Selvin, 2003, Ge, et al., 2004, Häussinger, et al., 2009].  Synthesis of a 
small molecule chelator amenable to click chemistry was demonstrated [Martin, et al., 
2010], however, the synthesis required many steps and utilized organic reagents; in 
addition, the chelator was clicked into a synthetic azide-containing peptide rather than 
an azide-containing protein target.   
To yield site-specific labeling of a protein of interest with a fluorescent or 
paramagnetic tag, I hypothesized that cyclooctyne-mediated copper-free click chemistry 
[Jewett and Bertozzi, 2010, Gordon, et al., 2012] may be coupled  with incorporation of 
an unnatural amino acid such as paF [Chin, et al., 2002] to yield a protein labeled with a 
85 
 
lanthanide chelator.  Therefore, I sought to synthesize a small-molecule lanthanide 
chelator amenable to copper-free click chemistry-mediated incorporation into the target, 
paF-containing protein, using aqueous conditions.  Consequently, the unprecedented 
two-step aqueous synthesis of a lanthanide chelator amenable to site-specific 
incorporation is herein described using dibenzylcyclooctyne-amine (DBCO-amine) and 
the small molecule lanthanide chelator diethylenetriaminepentaacetic acid (DTPA) 
(Figure 4.1).   
As its name implies, DTPA contains 5 carboxylic acid moieties (Figure 4.1, panel 
A).  Briefly, lanthanide was first chelated with DTPA to confer reaction specificity at 
DTPA’s central carboxylic acid prior to amide coupling with DBCO-amine.  Terbium, a 
paramagnetic lanthanide, was chosen for its unparalleled ability to induce 
pseudocontact shifts, large paramagnetic relaxation enhancements (PREs) [Otting, 
2008], attomolar DTPA binding affinity [Cacheris, et al., 1987], and ability to elicit 
substantial fluorescence intensity [Horrocks, 1993, Lakowicz, 1999].  The lanthanide, 
because of its attomolar affinity, remains chelated throughout synthesis and purification.  
The entire synthetic route is described in more detail, in the following section. 
Metallation of DTPA (molecule A, Figure 4.1) with terbium was performed to 
generate metallated DTPA (complex B), which conferred amide coupling reaction 
specificity at DTPA’s central carboxylic acid.  Metallated DTPA was then reacted with 
the cyclooctyne-containing molecule dibenzylcyclooctyne-amine (DBCO-amine (C)), 
which was applied to an amide coupling reaction to synthesize the clickable chelator 
(D).  Finally, in a copper-free click chemistry reaction, the clickable chelator (D) reacted 
with the unnatural amino acid paF (E), to generate the clicked clickable chelator (F).  
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The entire synthesis was performed in aqueous buffers under relatively mild conditions 
(~2-75˚C), with common reagents and commercially-available separation matrices (GE 
Healthcare).  Successful completion of the efforts described herein provides a new tool 
for expanding NMR and x-ray crystallography approaches to study relatively larger 
proteins and protein dynamics of complexes heretofore not facile.  Fluorescence and 
HPLC data indicated that the chelator synthesis was successful. 
 
4.2 Results and Discussion 
Metallation of DTPA 
The first step in the 2-step aqueous synthesis of the clickable lanthanide chelator 
was metallation of the chelator with terbium.  As shown in Figure 4.2, prior to metallation 
incubation, 350 nm excitation of 100 mM MES, pH 5.5, or 10 mM DTPA in 100 mM 
MES, pH 5.5, did not yield emissions between 400 and 800 nm save for the water 
Raman (702 nm).  Under the same experimental conditions, 40 mM terbium trichloride 
in 100 mM MES, pH 5.5, yielded four sharp emission peaks at 489, 544, 584, and 621 
nm, each of which exhibited substantial fluorescence intensity; the water Raman was 
evident at 702 nm.  Ten millimolar DTPA with 40 mM terbium trichloride in 100 mM 
MES, pH 5.5, yielded four sharp emission peaks at 489, 544, 584, and 621 nm, each of 
which exhibited greater fluorescence intensity than did 40 mM terbium trichloride, alone; 
the water Raman was evident at 702 nm.   
These fluorescence data demonstrated that DTPA chelated terbium and 
imparted substantial fluorescence emission at specific wavelengths: 489, 544, 584, and 
621 nm.  Because 1) DTPA was devoid of pi electrons and did not impart substantial 
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Figure 4.1: Synthetic route of Clickable Chelator and Clicked Clickable Chelator.  
Metallation of DTPA (A) with terbium (Tb+3) to form metallated DTPA (DTPA:Tb) (B).  
Amide coupling of metallated DTPA (DTPA:Tb) (B) to dibenzylcyclooctyne-amine 
(DBCO-amine) (C) to synthesize the clickable chelator (D).  Copper-free click chemistry 
reaction between the clickable chelator (D) and para-azidophenylalanine (paF) (E) to 
generate the clicked clickable chelator (F).  Single product shown. 
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fluorescence emission and 2) terbium imparted emissions at 489, 544, 584, and 621 
nm, demonstrated that the observed emission of metallated DTPA (DTPA:Tb) resulted 
from terbium fluorescence, not from DTPA.  Increased fluorescence intensity of the 
metallated DTPA relative to terbium, alone, indicated that DTPA chelates terbium. 
Based on efforts of Häussinger and coworkers [2009], it was thought that 
incubation at 75˚C would be required to facilitate metallation of terbium with DTPA.  We 
observed, however, that metallation incubation at 75˚C for 8.25 hours failed to increase 
the intensity of the fluorescence emissions for 10 mM DTPA with 40 mM terbium 
trichloride in 100 mM MES, pH 5.5.  This suggested that metallation of DTPA with 
terbium may be achieved with the thermal energy required to dissolve 10 mM DTPA in 
100 mM MES, pH 5.5. 
Compared to 10 mM DTPA in 100 mM ammonium acetate, pH 5.5 and 40 mM 
terbium in 100 mM ammonium acetate, pH 5.5, 1D NMR analysis of DTPA:Tb yielded 
broadened DTPA peaks, indicating complex formation or metal coordination of terbium 
with DTPA (Figure 4.3).  A new peak at ~14.0 ppm most likely corresponded to a 
coordinated water molecule.  As with the fluorescence results, the 1D NMR +/-
incubation spectra were nearly identical, suggesting that metallation of terbium 
trichloride by DTPA was achieved using incubation at 75˚C (the temperature used to 
dissolve 10 mM DTPA (chapter 2)), for 8.25 hours, although incubation did not appear 
to be mandatory to metallate DTPA with terbium.  In addition, these data suggested 
that, in the presence of a 4-fold molar excess of terbium, the reaction went to 
completion.  Consequently, all 10 mM DTPA was metallated with terbium. 
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Figure 4.2: Spectrum of fluorescence intensity (counts per second (cps)) of emission of 
100 mM MES, pH 5.5 (blue trace), 10 mM DTPA in 100 mM MES, pH 5.5 (black trace), 
40 mM terbium (Tb) in 100 mM MES, pH 5.5 (green trace), and metallated DTPA 
(DTPA:Tb) (red trace) in 100 mM MES, pH 5.5 upon excitation at 350 nm.  Peaks at 
489, 544, 584, and 621 nm correspond to terbium. The peak at 702 nm corresponds to 
the water Raman. 
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The fluorescence and 1D NMR data corroborated the conclusions that DTPA 
chelated terbium, the reaction went to completion, incubation was not required if DTPA 
dissolution was achieved with heat, and DTPA:Tb imparted unique and substantial 
fluorescence emission peaks at specific wavelengths 489, 544, 584, and 621 nm. 
 
Metallated DTPA Purified by Anion Exchange Chromatography 
Anion exchange chromatography was used to separate excess, positively-
charged terbium from negatively charged metallated DTPA.  Excess unmetallated 
positively-charged terbium eluted in the column void volume.  Because the metallation 
incubation included 4-fold molar excess of terbium, the fluorescence intensity 
associated with free, excess terbium should be greater than that of metallated DTPA.  
As expected, substantial fluorescence intensity at 489, 544, 584, and 621 nm was 
observed in anion exchange fractions 1-4 (Figure 4.4), which corresponded to the 
excess unchelated terbium present in the DTPA metallation incubation.   
Metallated DTPA contained a single carboxylic acid that associated with the 
column matrix’s positive charge.  Addition of sodium chloride displaced metallated 
DTPA from the column resin; consequently, fluorescence emission corresponding to the 
terbium in metallated DTPA is expected in fractions from the sodium chloride gradient.  
As expected, elution with sodium chloride elicited fluorescence intensity at emission  
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Figure 4.3: 1D NMR analysis of 10 mM 
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Figure 4.4: Cumulative fluorescence intensity in counts per second (cps) (left y-axis) of 
emissions at 489, 544, 584, and 621 nm of 3.5-mL fractions collected during anion 
exchange chromatography separation of metallation reaction.  Excitation was at 350 
nm.  The x-axis depicts the anion exchange fraction number; the right y-axis depicts the 
1M sodium chloride (NaCl) gradient (black dashed line). 
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wavelengths 489, 544, 584, and 621 nm in fractions 10, 11, and 12, which 
corresponded to terbium-metallated DTPA.  In addition, the cumulative fluorescence 
intensity of the free, excess terbium (Fractions 1-4) was greater than that of metallated 
DTPA (Fractions 10-12).  These results indicated that metallated DTPA may be 
separated from excess terbium.  Fraction 11 was used for amide coupling.  
 
DBCO-amine Fluorescence Excitation and Emission Maxima 
As shown in Figure 4.5, fluorescence excitation and emission maxima were 
determined on 193.5 µM DBCO-amine in 3.2% (v/v) DMSO in 100 mM MES, pH 5.5.  A 
moderately sharp emission peak, with maximum at 383 nm and a broad emission band 
with a maximum at 740 nm was observed.  The excitation maximum was 259 nm.  The 
water Raman was evident at 519 nm.  Based on the aromatic character of the 
dibenzylcyclooctyne moiety, this was most likely the region of the molecule, not the free 
amine, which imparted the observed fluorescence. 
 
Fluorescence of G10 Fractions 
The second step in the 2-step aqueous synthesis of the clickable lanthanide 
chelator was amide coupling.  Reactants for amide coupling, metallated DTPA and 
DBCO-amine, which were 548 and 276 Da, respectively, were retained within the G10 
Sephadex matrix.  In contrast, the amide coupling reaction product, the clickable 
chelator, at 802 Da, was excluded from the matrix and eluted in the void volume.  
Because metallated DTPA, DBCO-amine, and the clickable chelator each imparted  
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Figure 4.5: Spectra of fluorescence emission (Panel A) and excitation (Panel B) scans 
of 193.5 µM DBCO-amine in 3.2% (v/v) DMSO in 100 mM MES, pH 5.5, with Panel C 
depicting the excitation reference scan.   The water Raman is evident at 519 nm in the 
emission scan (Panel A).  The emission and excitation maxima were determined to be 
383 and 259 nm, respectively.  Wavelength (nm) is depicted on each x-axis; intensity in 
counts per second (cps) is depicted on panels A and B y-axes while intensity in 
MicroAmps is depicted on Panel C y-axis. 
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unique and substantial fluorescence signatures, fluorescence analysis of the fractions 
collected from G10 Sephadex would indicate the presence of these molecules in each 
fraction.   
Upon excitation at 350 nm, the first collected fraction from the G10 Sephadex 
column yielded emission peaks at 489, 544, 584, and 621 nm (Figure 4.6).  Because 
terbium emits at 489, 544, 584, and 621 nm, the fluorescence intensity of G10 Fraction 1 
is imparted by terbium.  In addition, G10 Fraction 1 exhibited substantial fluorescence 
intensity at an emission of 429 nm.  Based on the structure of the dibenzylcyclooctyne 
moiety and the fluorescence character of DBCO-amine alone (Figure 4.5), the 
fluorescence emission at 429 nm most likely corresponded to the DBCO- moiety.  No 
other collected G10 Sephadex fractions exhibited dual emissions from terbium and 
DBCO although several subsequent fractions exhibited fluorescence associated with 
excess DBCO present in the amide coupling reaction (data not shown).  That a single 
fraction 1) possessed fluorescence character that corresponded to DBCO- and to 
metallated DTPA and 2) eluted in the void volume demonstrated that both DBCO- and 
metallated DTPA were present in one entity that is larger than 700 Da.  Therefore, this 
data indicated that synthesis of the clickable chelator was successful.  
 
HPLC Analysis of G10 Fraction 1 Yields Single Peak 
HPLC analysis of G10 Fraction 1 yielded a single, sharp peak with a retention 
time of approximately 7 minutes (Figure 4.7).  This fraction may be collected for small-
molecule mass spectrometry to determine the nature of the molecule(s) that yielded the 
single HPLC peak. If the mass spectrometry data indicate that one product is present, 
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Figure 4.6: Emission scan of Fraction 1 collected from G10 Sephadex separation.  
Arrows correspond to emission wavelengths 429, 489, 544, 584, and 621 nm.  The 
water Raman was evident at 702 nm.  Excitation was at 350 nm.  The x-axis depicts 
wavelength (nm) and the y-axis the fluorescence intensity (cps). 
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Figure 4.7: HPLC analysis of Fraction 1 collected from G10 Sephadex purification of the 
amide coupling reaction.  Absorbance (mAU) is depicted on the left y-axis, retention 
time (minutes) on the x-axis, and %B (light blue trace) on the right y-axis. 
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these data suggest that the amide coupling yielded a single product that eluted in the 
void volume of the G10 Sephadex matrix. 
 
Fluorescence Analysis of Clickable Chelator Yields Distinct Maxima 
Excitation maximum of the clickable chelator was 322 nm; the emission 
maximum was 429 nm.  An excitation wavelength of 322 nm did not yield discernible 
terbium fluorescence peaks and likely corresponded to fluorescence associated with the 
dibenzylcyclooctyne- moiety in the clickable chelator.  Excitation of the clickable 
chelator at 350 nm yielded terbium-associated emission peaks at the predicted 
wavelengths of 489, 544, 584, and 621 nm.  These data demonstrated that the clickable 
chelator possessed unique fluorescence properties, which originated from its dual 
DBCO- and terbium constituents.  
 
Copper-free Click Chemistry Reaction with Clickable Lanthanide Chelator 
Para-azidophenylalanine (azide) eluted from a C18 stationary phase in a single 
peak at 5.5 minutes (Figure 4.8); clickable chelator (alkyne) eluted in a single peak at 7 
minutes.  HPLC separation of an aliquot of the 10:1 alkyne:azide yielded two sharp 
peaks, the first at 6 minutes, which corresponded to the copper-free click chemistry 
reaction product, the clicked clickable chelator, and the second at 7 minutes, which 
corresponded to the excess alkyne, the clickable chelator.  The peak at 6 minutes 
exhibits a retention time unique from that of the reactants paF (5.5 minutes) and the 
clickable chelator (7 minutes).  This result indicated that the copper-free click chemistry 
reaction yielded a product with a unique retention time.   
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Figure 4.8: HPLC analysis of the reactant paF and the 10:1 alkyne: azide copper-free 
(cu-free) click chemistry reaction between paF (azide) and the clickable chelator to 
generate a clicked clickable chelator.  Absorbance (mAU) is depicted on the left y-axis, 
retention time (minutes) on the x-axis, and %B (light blue trace) on the right y-axis. 
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Mass Spectrometry of Clickable Chelator  
Select HPLC fractions from the copper-free click chemistry reactions were 
analyzed by MALDI mass spectrometry, however, the presence of additional peaks in 
the experimental and control spectra stymied data interpretation.  Additional small-
molecule mass spectrometry analyses of the clickable chelator and the clicked clickable 
chelator would ascertain peak assignments, and are discussed in more detail in chapter 
6. 
 
4.3 Conclusions 
Lanthanide incorporation is a promising strategy to expand the utility of structural 
biology approaches NMR and x-ray crystallography, offering the ability to evaluate 
protein dynamics, conformational changes, and interactions of larger proteins than have 
previously been studied.  The requirement for site-specific incorporation, however, 
coupled with the need for aqueous synthesis of a small-molecule chelator, has limited 
lanthanide use with these approaches.  A new approach for site-specific lanthanide 
incorporation is articulated herein whereby a 2-step aqueous synthesis of a small 
molecule lanthanide chelator amenable to copper-free click chemistry is described using 
diethylenetriaminepentaacetic acid, terbium trichloride, and dibenzylcyclooctyne-amine.   
 
Metallation of DTPA 
The first step in the synthesis of a small-molecule lanthanide chelator amenable 
to copper-free click chemistry-mediated site-specific incorporation into the protein of 
interest was to metallate the chelator with the lanthanide of interest.  For these studies, 
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diethylenetriaminepentaacetic acid (DTPA) and the lanthanide terbium were chosen.  
Metallation of DTPA with terbium was achieved first using 100 mM ammonium acetate, 
pH 5.5, using conditions that had already been utilized for similar objectives 
[Häussinger, et al., 2009].  Subsequently, metallation of DTPA with terbium was 
achieved using a buffer devoid of free amines, 100 mM MES, pH 5.5.  Notably, the use 
of buffers containing free amines, such as ammonium acetate, should be avoided for 
the metallation incubation, as the free amines in the buffer may react with the carboxylic 
acid of the chelator during the amide coupling reaction.  Although it is possible to 
perform buffer exchange between the metalation and amide coupling steps, the use of 
an appropriate buffer for the metallation incubation should be considered for efficiency.  
While buffer exchange may be facilitated during anion exchange separation of the 
metallation reaction, the use of one buffer for metallation and anion exchange 
separation also prevents the need to optimize buffer exchange. 
Metallation of DTPA with terbium was performed at a 1:4 molar stoichiometry of 
DTPA:TbCl3 and metallated DTPA was purified from excess terbium using anion 
exchange chromatography.  We thereby demonstrated the ability to metallate DTPA 
with terbium; it is expected that metallation of other chelators with a variety of other 
lanthanides may also be achieved. 
 
Clickable Chelator Synthesized 
Metallation of DTPA with terbium electrostatically engaged DTPA’s peripheral 
four carboxylic acids with terbium’s positive charge, leaving the central carboxylic acid 
of DTPA available to react with a cyclooctyne-containing molecule, dibenzyl-
102 
 
cyclooctyne-amine (DBCO-amine), for synthesis of the clickable chelator by amide 
coupling.  A room temperature, 120-minute amide coupling reaction of DTPA metallated 
with terbium was performed with an estimated 5-fold molar excess of DBCO-amine in 
the presence of the amide coupling reagent 1-ethyl-3-(3-dimethylamino-propyl)-
carbodiimide (EDC).  Separation of reactants DTPA:Tb and DBCO-amine and the 
product, DBCO-DTPA:Tb, was achieved by size-exclusion chromatography.  
Subsequently, fluorescence and HPLC analyses of the size-exclusion chromatography 
fractions demonstrated that the synthesis yielded a single product that elicited 
fluorescence emission corresponding to both the dibenzylcyclooctyne moiety and 
terbium.  The next step was to perform a copper-free click chemistry reaction between 
the small molecules paF and DBCO-DTPA:Tb.  
 
Copper-free Click Chemistry Reaction 
In order to evaluate whether or not the clickable chelator contained a cyclooctyne 
amenable to copper-free click chemistry, a reaction was performed between the 
clickable chelator and the small molecule unnatural amino acid paF.  HPLC analysis of 
the click chemistry reaction yielded a distinct, single peak with a slightly earlier retention 
time compared to the peak that corresponded to the clickable chelator.  This result 
suggested that the copper-free click chemistry reaction yielded a new product; because 
of the reactivity of the azide and cyclooctyne molecules, the most likely conclusion from 
these data was that the cyclooctyne was present in the clickable chelator and it reacted 
with the unnatural amino acid paF. The next step is to administer the DBCO-DTPA:Tb 
(the clickable chelator) to paF-containing Survivin protein.  Once that is accomplished, 
103 
 
15N-backbone-labeled paF-containing Survivin protein will be generated; the clickable 
chelator will be added in a copper-free click chemistry reaction.  After purification of the 
labeled Survivin protein, NMR analyses will be performed on Survivin with its binding 
partners. 
 
In summary, the synthesis of a small-molecule lanthanide chelator amenable to 
copper-free click chemistry-mediated incorporation into a protein of interest is herein 
described using relatively mild reaction conditions and common reagents, with aqueous 
buffers, and two very straightforward purification steps that require common, 
commercially-available matrices and buffers.  This is the first description of a 2-step 
synthesis of a small-molecule lanthanide chelator amenable to copper-free click 
chemistry-mediated incorporation into the protein of interest, using aqueous conditions.  
The synthesis yields a small-molecule lanthanide chelator that may be utilized in a 
variety of NMR- and fluorescence-based experiments that monitor protein-protein 
interactions. 
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Chapter 5: A High-Throughput Fluorescence Polarization Small-Molecule 
Screening Assay for Identification of Inhibitors of the Survivin-Histone-3 Protein-
Peptide Interaction 
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5.1 Introduction 
Efforts are ongoing to identify novel lead compounds that may serve as structural 
scaffolds which may be further altered chemically to produce drugs that exhibit a 
therapeutic effect on a relevant target.  Hence, an abundance of high-throughput 
screening (HTS) platforms have been optimized for the identification of promising lead 
candidate compounds for use as therapies in many different diseases.  
High-throughput screening can be conducted using a variety of chemical 
compound libraries.  The Prestwick Chemical Library® [www.prestwick.com] is 
comprised of 1280 small molecules drugs approved by the Food and Drug 
Administration (FDA) and European Medicines Agency (EMA).  The Prestwick Chemical 
Library® compounds exhibit high pharmacological and chemical diversity; their safety, 
bioavailability, and pharmacokinetic profiles in humans are known.  The ZINC (ZINC is 
not commercial) library [Irwin and Shoichet, 2005] contains 727,842 commercially-
available small molecules.  ZINC is a virtual library produced for facile computational 
screening.   
Each library is designed to facilitate the most efficient transition from in vitro 
screening to clinical utility.  Thus, parameters such as oral bioavailability, compliance 
with Lipinski’s rules, solubility, and safety, when available, are considered.  
One drawback to utilization of these chemical compound libraries is the vast size 
and consequent large expense incurred testing thousands of compounds without any 
initial information about how the compound(s) may bind the target protein.  Another 
drawback is that it may be difficult or cost-prohibitive to purify sufficient quantities of 
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target protein to screen hundreds or thousands of compounds, then follow-up with the 
requisite secondary analyses. 
In silico analyses can generate structural predictions about how small molecules 
might bind putative protein targets.  Such predictions may include hydrogen bonding 
interactions, electrostatics, and bond distance information, all of which can be used to 
determine whether or not the small molecule binding interaction observed in silico may 
have a likelihood of translating to an in vitro experimental observation.  One such in 
silico approach, developed by Karanicolas and coworkers, can model the structure of 
the protein target in the presence of a protein binding partner with different small 
molecule candidate inhibitors [Karanicolas and Kuhlman, 2009, Karanicolas, et al., 
2011, Sievers, et al., 2011, Johnson and Karanicolas, 2013].  This computational 
approach has the potential to identify promising candidates that may yield optimal in 
silico to in vitro translation; these select candidates can then be analyzed within the 
fluorescence polarization assay described below.  This “rational screening” approach 
may decrease the time and expense involved in identifying candidate inhibitors because 
only select candidates identified from the computational screen are analyzed by 
fluorescence polarization. 
The ratio of vertically- and horizontally-polarized fluorescence intensity yields the 
fluorescence polarization value (chapter 1).  To identify candidate inhibitors of a specific 
protein-protein interaction, protein and fluorescently-labeled peptide are combined at 
fixed concentrations, then fluorescence anisotropy or polarization is measured.  Small 
molecule inhibitors will disrupt the protein-peptide binding interaction, eliciting a 
decrease in the observed fluorescence anisotropy or polarization signal.  Promising 
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small molecule candidate inibitors that elicit decreased fluorescence anisotropy or 
polarization are then screened for autofluorescence and quenching [Gribbon and 
Sewing, 2003], two factors that may alter the fluorescence polarization or anisotropy 
signal independent of disruption of the protein-protein interaction, leading to false 
positives or false negatives.  Candidate molecules that are not false positives or 
negatives may then be tested further to determine IC50 for the protein-peptide 
interaction.  Candidates may then be subjected to additional screening such as two-
dimensional heteronuclear single quantum coherence (2D-HSQC) chemical shift 
perturbation NMR or x-ray co-crystallography, which may give information about the 
ability of the small molecule to displace the peptide from the target protein. 
Fluorescence polarization may be most useful when the protein target is non-
enzymatic and/or participates in many intracellular pathways.  The platform is amenable 
to high-throughput analysis in 96- or 384-well plate formats, and can accommodate 
relatively small (100-200 µL for 96-well format, for example) assay volumes, facilitates 
analysis of specific- and non-specific binding, is performed in solution rather than via 
attachment of the target protein or peptide to a rigid substratum or antibody, utilizes 
relatively common instrumentation (fluorescence plate reader with adjustable excitation 
and emission polarizers), and can be adapted to evaluate false positives and false 
negatives.  Depending on the fluorophore and fluorometer utilized, the method can be 
relatively sensitive.  Taken together, these advantages can facilitate relatively 
straightforward and rapid identification of candidate protein-protein interaction inhibitors. 
In previous studies, the HTS FP platform has been used to identify inhibitors of 
the X-linked Inhibitor of Apoptosis protein (XIAP) [Liu, et al., 2000, Nikolovska-Coleska, 
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et al., 2004, Nikolovska-Coleska, et al., 2008] and for identifying small molecule 
Smac/DIABLO mimics [Glover, et al., 2003].  HTS assays have been sought for the 
identification of inhibitors of Survivin’s protein-protein interactions, due to its important 
role in cancer cell survival and cell division.  However, finding the appropriate protein-
protein interaction to target among Survivin’s many protein partners has been 
challenging.   
Survivin binding histone-3 is a critical event in facilitating chromosomal 
passenger complex-mediated chromosomal segregation [reviewed in Carmena, et al., 
2012].  Therefore, inhibiting Survivin-histone-3 binding may disrupt chromosomal 
passenger complex assembly, resulting in G2/M arrest and cell death, an important 
outcome in cancer cells.  An efficacious, selective inhibitor of Survivin protein-protein 
interactions has thus far eluded researchers and no fluorescence polarization-based 
Survivin inhibitor screening assays have been established.  We hypothesize that high-
throughput screening of candidate Survivin-histone-3 protein-peptide inhibitors may be 
accomplished using the fluorescence polarization platform.  Successful completion of 
the work described herein will produce a validated assay to identify potential Survivin-
histone-3 protein-peptide inhibitors. 
 
5.2 Results and Discussion 
 Survivin1-120 was over-expressed, purified, cleaved with thrombin, and analyzed 
by Coomassie, silver stain, and whole-peptide mass spectrometry.  Uncleaved and 
thrombin-cleaved Survivin1-120 yielded a sharp, dense, single band at the molecular 
weights that corresponds to uncleaved (~15 kD) and thrombin-cleaved Survivin1-120 (14 
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kD) (Figure 5.1).  Coomassie and silver stain results were corroborated by whole-
peptide mass spectrometry, which yielded a sharp peak near the theoretical mass of 
thrombin-cleaved Survivin1-120 (14095.9 Da) at 14094.4 Da (Figure 5.2).  These data 
suggest that cleavage and purification of Survivin1-120 was successful. 
 
Histone-3 Peptide Binds Thrombin-Cleaved Survivin1-120 
As shown in Figure 5.3, excitation and emission maxima of carboxyfluorescein-
labeled histone-3* (H3*) were determined to be 493 and 522 nm, respectively.   
In order to determine if H3* bound thrombin-cleaved Survivin1-120, 100 nM H3* 
was titrated with increasing amounts of thrombin-cleaved Survivin1-120.   As shown in 
Figure 5.4, increasing amounts of thrombin-cleaved Survivin1-120 yielded a higher 
percent fluorescence polarization and percent fluorescence anisotropy.  H3* binding 
appeared to approach saturation as the concentration of thrombin-cleaved Survivin1-120 
reached 20 µM.  The experimental design was such that the amount of bovine gamma 
globulin (BGG) was constant in each experiment, to maintain viscosity of the 
experimental sample, thus, this result suggested that H3* bound thrombin-cleaved 
Survivin1-120, not BGG.   
In order to determine if H3* bound uncleaved Survivin1-120, 100 nM H3* was 
titrated with increasing amounts of uncleaved Survivin1-120.   As shown in Figure 5.5, 
increased thrombin-cleaved Survivin1-120 yielded a higher percent fluorescence 
polarization and percent fluorescence anisotropy.  H3* binding did not approach 
saturation as the concentration of thrombin-cleaved  Survivin1-120 reached
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Figure 5.1: SDS-PAGE separation followed by Coomassie staining of Survivin1-120 (~15 
kD) before (Panel A) and after (Panel B) thrombin cleavage and purification. 
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36 µM.  The experimental design was such that the amount of bovine gamma globulin 
(BGG) was constant in each experiment, as above.  The linear increase in percent 
fluorescence polarization and percent fluorescence anisotropy may have corresponded 
to non-specific binding of H3* to uncleaved Survivin1-120.  One possible source of non-
specific binding may be uncleaved Survivin1-120 aggregates: improperly folded 
uncleaved Survivin1-120 may present non-specific binding opportunities to H3*, giving 
rise to the observed increase in percent fluorescence polarization and anisotropy 
(Figure 5.5).   
Because the His6- tag was at the extreme N-terminus of Survivin and histone-3 
binds Survivin’s BIR domain, the presumption was that the His6-tag would not interfere 
with histone-3 peptide binding.  The data presented in Figure 5.5, however, possibly 
suggests that uncleaved Survivin1-120 did not adopt or retain its properly-folded tertiary 
conformation that facilitates specific H3* binding.  Subsequent experiments utilized 
uncleaved His6-Survivin1-120, however, cleaved Survivin1-120 would likely have yielded 
more reliable results. 
 
Analysis of Survivin-Histone-3 Binding Specificity 
The specificity of the Survivin:H3* binding interaction was evaluated by titrating 
unlabeled histone-3 peptide into 30 µM His6-Survivin1-120 and 1 µM H3* in 100 mM 
potassium phosphate, pH 7.5; as shown in Figure 5.6, the addition of an increasing 
amount of H3 decreased fluorescence polarization, however, a large standard deviation 
of 42% in the 0 nM H3 sample introduced question about the validity of the data.  It is  
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Figure 5.3: Emission scan (Panel A) and excitation scan (Panel B) of 100 nM 
carboxyfluorescein-labeled histone-3 (H3*) peptide in 100 mM potassium phosphate, 
pH 7.5, with excitation reference scan (Panel C).  The emission and excitation maxima 
were 522 nm and 493 nm, respectively.  Wavelength (nm) is depicted on each x-axis; 
intensity in counts per second (cps) is depicted on panels A and B y-axes while intensity 
in MicroAmps is depicted on Panel C y-axis. 
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Figure 5.4: Percent fluorescence anisotropy (%r) (Panel A) and percent fluorescence 
polarization (%P) (Panel B) of thrombin-cleaved Survivin1-120, in the presence of 100 nM 
fluorescein-labeled histone 3 peptide (H3*) in 100 mM potassium phosphate, pH 7.5, 
100 µg/mL bovine gamma globulin, 0.02% (w/v) sodium azide.  A: Percent fluorescence 
anisotropy (%r) with increasing concentration of thrombin-cleaved Survivin1-120.  B: 
Percent fluorescence polarization (%P) with increasing concentration of thrombin-
cleaved Survivin1-120.  Fitted line is shown for reference only. 
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Figure 5.5: Percent fluorescence anisotropy (%r) (Panel A) and percent fluorescence 
polarization (%P) (Panel B) of uncleaved His6-Survivin1-120, in the presence of 100 nM 
fluorescein-labeled histone 3 peptide (H3*) in 100 mM potassium phosphate, pH 7.5, 
100 µg/mL bovine gamma globulin, 0.02% (w/v) sodium azide.  A: Percent fluorescence 
anisotropy (%r) with increasing concentration of uncleaved Survivin1-120.  B: Percent 
fluorescence polarization (%P) with increasing concentration of uncleaved Survivin1-120.  
Line is only shown for reference purposes. 
% P 
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difficult to see a compelling trend of decreased fluorescence polarization with the 
addition of increased H3.  In addition, the experiment included uncleaved Survivin1-120, 
and as discussed previously, H3* may non-specifically bind uncleaved Survivin1-120. 
Therefore, the conclusion that can be made from these results is that the experiment 
should be repeated using thrombin-cleaved Survivin1-120.   
 
Computational Screen Identifies Promising Survivin-Histone-3 Inhibitors 
Computational screening of several hundred compounds using a Survivin 
conformation that binds histone-3 peptide was performed (Karanicolas Laboratory, 
University of Kansas, Lawrence, Kansas).  Numerous compounds (Figure 5.7) were 
identified that bound Survivin at the Survivin-histone-3 binding interface.  These 
compounds will be evaluated using the fluorescence polarization assay to determine if 
they displace histone-3 peptide from Survivin1-120. 
 
Identifying False Positives by Analyzing Candidate Inhibitor Propensity to 
Quench Fluorescence Polarization 
As was described in chapter 1, the fluorescence polarization quantity is 
calculated using the instrument outputs of vertical and horizontal fluorescence 
intensities.  Therefore, changes in fluorescence intensity, due to quenching, can alter 
the fluorescence polarization value.  Quenching of fluorescence intensity can occur by a 
variety of processes.  Non-radiative decay of the excited photon to the surrounding 
media can decrease fluorescence intensity.  Because decreased fluorescence 
polarization can also result from disrupted protein-peptide binding, any compounds that 
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Figure 5.6: Fluorescence polarization (y-axis) as a function of increasing amounts of 
unlabeled histone-3 peptide (log nM, x-axis) added to 1 µM H3* and 30 µM uncleaved 
Survivin1-120 to evaluate binding specificity of H3* for uncleaved Survivin1-120. 
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Alias Chemical name
JK15 5-[(1,3-benzothiazol-2-ylmethyl)sulfanyl]-4H-1,2,4-triazol-3-amine
JK16 1-[(1-phenyl-1,2,3,4-tetrazol-5-yl)methyl]-1,2,4-triazole-3-carbonitrile
JK18 1-methyl-4-[(3-phenyl-1H-pyrazol-4-yl)methyl]piperazine
JK19 2-amino-5-(4-chlorophenyl)-1,3-thiazole-4-carbohydrazide
JK20 4-(((3-(2-furyl)-5-mercapto-4H-1,2,4-triazol-4-yl)imino)methyl)phenol
JK21 6-[2-(1H-imidazol-4-yl)ethyl]-6,7-dihydro-5H-pyrrolo[3,4-b]pyridin-5-one
JK15
JK16 JK18JK15
JK19
JK20
JK21
  
Figure 5.7: Candidate Survivin-histone-3 protein-protein interaction inhibitors identified 
by computational screening performed in the Karanicolas laboratory. 
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yield a decreased fluorescence signal would need to be evaluated for both their 
propensity to quench the fluorescence signal and their ability to disrupt protein-peptide 
binding, which may be completed in a secondary assay. Application of candidate 
inhibitors to the Survivin-histone-3 protein-peptide interaction may elicit decreased 
fluorescence polarization.  Two interpretations of this outcome are possible.  First, the 
candidate inhibitor displaces fluorescently-labeled histone-3 peptide from Survivin.  
Displaced fluorescently-labeled histone-3 peptide tumbles quickly and yields virtually no 
fluorescence polarization.  Alternatively, the candidate inhibitor does not displace 
fluorescently-labeled histone-3 peptide from Survivin.  Rather, the candidate inhibitor 
quenches the fluorescence signal of the fluorescently-labeled histone-3 peptide while it 
remains bound to Survivin protein.  Consequently, the observed vertically and 
horizontally polarized fluorescence intensities are reduced and the ratio, the calculated 
fluorescence polarization value, approaches zero.  This scenario represents the false 
positive, where the candidate did not displace the fluorescently-labeled peptide but the 
fluorescence polarization result suggested that the fluorescently-labeled histone-3 
peptide was displaced from the Survivin protein.  To rule out false positives, the 
candidate inhibitor is evaluated for its propensity to quench the fluorescence intensity of 
the fluorescently-labeled histone-3 labeled peptide, in the absence of Survivin.  The 
experiment is performed by titrating increasing candidate inhibitor into a constant 
amount of fluorescently-labeled histone-3 peptide and monitoring fluorescence intensity 
of the labeled peptide.  To evaluate the contribution of both vertically- and horizontally-
polarized emission on the output of fluorescence polarization, it may be helpful to 
120 
 
determine the steady-state fluorescence intensities of the labeled peptide and candidate 
inhibitor, as well as the intensities using vertically- and horizontally-polarized light.  
Identifying False Negatives by Analyzing Candidate Inhibitor 
Autofluorescence 
In fluorescence polarization HTS, the drug candidate is tested at various 
concentrations.  If the candidate does not decrease the observed percent fluorescence 
polarization, two explanations are possible.  First, the candidate did not displace H3* 
from the Survivin protein, so the observed percent fluorescence polarization arises from 
the slowly tumbling, intact complex of H3* and Survivin.  As an alternative, the 
candidate displaced H3* from the Survivin protein, but the candidate’s fluorescence 
emission spectrum overlaps that of the monitored emission spectrum of H3*, so the 
observed percent fluorescence polarization arises from slowly tumbling candidate-
bound Survivin protein.  The second scenario represents the false negative where the 
candidate displaced H3*, but the fluorescence polarization result suggested that H3* still 
bound the Survivin protein.  To analyze candidates for autofluorescence, the candidate 
compound’s excitation and emission maxima should be determined in an experiment 
independent of the fluorescence polarization assay.   It also may be beneficial to titrate 
increasing amounts of inhibitor to Survivin, alone, to evaluate increased percent 
fluorescence polarization in the absence of H3*. 
  
Determination of Candidate Inhibitor IC50 
Candidates that 1) decrease fluorescence polarization 2) do not autofluoresce, 
and 3) do not quench H3* fluorescence will be further screened for their ability to disrupt 
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the Survivin:H3* binding interaction.  The concentration of inhibitor that elicits half-
maximal protein-peptide dissociation, IC50, will be determined by titration of candidate 
inhibitor into constant Survivin-histone-3* using the fluorescence polarization screening 
assay.   
 
Secondary Screen 
To structurally characterize candidate molecule inhibition of His6-Survivin1-
120:histone-3 peptide binding, nuclear magnetic resonance spectroscopy or x-ray 
crystallography experiments may be performed on 15N-backbone-labeled thrombin-
cleaved Survivin1-120 or unlabeled thrombin-cleaved Survivin1-120, respectively, with 
unlabeled histone 3 peptide, in the presence of the candidate inhibitor. 
 
Our preliminary analyses using a cuvette-based fluorescence polarization 
platform indicated that H3* bound thrombin-cleaved Survivin1-120, however a dissociation 
contant should be determined from additional experiments with thrombin-cleaved 
Survivin1-120.  H3* bound uncleaved Survivin1-120 apparently non-specifically.  This 
cuvette-based finding regarding uncleaved Survivin1-120 was corroborated in the plate 
fluorometer platform, where the polarization increased linearly with increased uncleaved 
Survivin1-120 concentration.  For this reason, conclusions made on histone-3 binding to 
uncleaved Survivin1-120 regarding pH dependence, temperature, and DMSO content 
cannot be interpreted.  Prior to screening to identify candidate inhibitors, these analyses 
will need to be repeated using thrombin-cleaved Survivin1-120. 
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5.3  Conclusions 
 Fluorescence polarization-based screening presents advantages over other 
approaches for the identification of protein-protein interaction inhibitors, especially for 
non-enzymatic protein targets.  The protein and peptide binding partner are combined in 
solution, rather than on a rigid substratum or via antibody-mediated recognition.  In 
addition, the 96-well plate format utilizes relatively small sample volumes and relatively 
low protein concentrations compared to NMR or x-ray crystallography approaches, may 
be completed in a short period of time, can be optimized to yield sufficient signal:noise 
ratio, and can be performed at a variety of incubation temperatures as well as excitation 
and emission wavelengths different from those of naturally-occurring fluorophores.  
Several limitations and caveats, however, should be considered for the most 
conservative data interpretation, including that of non-specific fluorescently-labeled 
peptide binding and improper target protein folding within the experimental matrix.  
When considering these limitations and ruling out false positives and negatives, 
fluorescence polarization may be a useful method to identify candidate protein-peptide 
interaction inhibitors, presenting yet another avenue to bring therapeutics to the clinic 
for many human diseases.  
Our objective was to establish a screening assay to identify inhibitors of the 
Survivin-histone-3 protein-peptide binding interaction.  Herein is described the 
foundation for a fluorescence polarization assay for Survivin1-120 and histone-3 peptide 
that can be used to evaluate candidate inhibitors identified by an in silico screen 
performed in the Karanicolas laboratory. 
 
123 
 
 
 
 
 
 
 
 
 
 
 
Chapter 6: Conclusions and Future Prospects 
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6.1 Introduction 
Chapter 3 described efforts to utilize click chemistry to site-specifically label the 
Survivin protein with a fluorophore, with the ultimate goal of facilitating fluorescence-
based protein-protein interaction studies of Survivin with its protein binding partners.  
Although the data described therein suggested that the fluorophore was adducted to the 
Survivin protein, additional analysis such as whole-protein mass spectrometry and 
tryptic digest followed by peptide mass spectrometry, could have augmented the data 
described in chapter 3.  These and other suggestions are the subject of subsequent 
sections of this chapter. 
 Chapter 4 described efforts to synthesize a lanthanide chelator amenable to 
copper-free click chemistry, the ultimate goal of which was to expand the utility of 
protein structure-determination methods such as x-ray crystallography and nuclear 
magnetic resonance spectroscopy.  Although fluorescence- and HPLC-based data 
described within chapter 4 suggest that synthesis of a clickable lanthanide chelator was 
successful, additional analyses that would corroborate this conclusion are described in 
subsequent sections of this chapter. 
 Chapter 5 concerned efforts to establish a fluorescence polarization assay to 
rapidly screen chemical libraries for the identification of candidate inhibitors of Survivin 
protein-protein interactions.  Additional analyses may be considered as an alternative to 
the approaches described therein.  
Collectively, although the methods described in chapters 3-5 may facilitate the 
development, through structure-aided design, or identification of small molecule inhibitor 
leads of selected protein targets, the proposed methods have limitations.  The following 
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chapter will address whether or not the objectives of each specific aim were obtained, 
the limitations of the approaches proposed in preceding chapters, and additional 
strategies to overcome the methodological limitations of the proposed approaches. 
 
6.2 Analyses to Evaluate Copper-free Click Chemistry Reaction Success with the 
Mutant Survivin Protein 
 Strategies to Confirm Mutant Survivin Protein Synthesis 
Regarding the utility of copper-free click chemistry to site-specifically incorporate 
a fluorescent probe into the Survivin protein, DNA sequences of all seven plasmids 
encoding mutant Survivin genes with the amber stop codon were correct and all seven 
mutants yielded Survivin protein, as observed by western blotting (chapter 3, Figure 
3.1).  These results suggest that the translated Survivin1-120 contained the unnatural 
amino acid paF, however, these results do not confirm inclusion of paF, nor do they 
provide information about the site of paF incorporation.  Mass spectrometry could 
confirm that: 1) the Survivin protein contained the unnatural amino acid paF and 2) the 
copper-free click chemistry-mediated adduction of DBCO488 fluorophore to paF was 
site-specific. 
 The molecular weight of His6-Survivin1-120 (uncleaved Survivin) is 15978.0 Da and 
the cleaved product (14094.4 Da) was easily detected using Linear Trap Quadrupole-
Fourier Transform (LTQ FT) mass spectrometry (chapter 5, Figure 5.2).  Therefore, 
mass spectrometry could also be used to confirm that the Survivin1-120 protein contained 
the unnatural amino acid paF.  The seven paF-containing Survivin1-120 mutants have 
following masses, and differences from the His6-Survivin1-120 mass, as outlined in Table 
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6.1.  Insertions of paF at the N- and C-termini and mutations F93paF, F101paF, and 
G99paF elicit changes in mass that could be detected using LTQ FT mass 
spectrometry.  The difference in mass of His6-Survivin1-120 and W10paF and W67paF, 
+1.975 Da, however, is more subtle.  Using Thermo Electron Corporation’s Finnegan 
LTQ FT instrument, which yields maximum resolution of 500,000 (FWHM) [Thermo 
Electron, 2003], it should be possible to detect a difference of 1.975 Da between 
tryptophan and paF, especially when evaluating peptide fragments instead of the whole 
protein mass spectrum shift.  Therefore, tryptic digest may be performed on whole-
protein W10paF or W67paF Survivin, and the resulting fragments evaluated to ascertain 
that positions 10 and 67 contain paF instead of tryptophan.  These analyses could 
confirm site-specific incorporation of paF into the His6-Survivin1-120 protein.   
 As was described in chapter 2, BL21*DE3 E. coli expressing the unnatural amino 
acyl tRNA synthetase may occasionally insert arginine at the amber stop codon; 
compared to paF, arginine insertion would yield the following masses, which are smaller 
than the intended mutant mass by -32.0 Da (the difference between paF and arginine) 
(Table 6.2).  As was discussed in chapter 2, this was the basis for selecting DH10B 
(TopTen) E. coli rather than BL21*DE3 E. coli.  
 
 
 
 
 
 
127 
 
Mutant Mass (Da)
Difference from His6-
survivin1-120 mass (Da)
NtermpaF, CtermpaF 16166.20 206.20
W10paF, W67paF 15979.98 1.98
F93paF, F101paF 16019.01 41.01
G99paF 15902.93 -75.07
 
 
 
 
 
 
Table 6.1: Masses of paF-containing His6-Survivin1-120 mutant proteins and differences 
from His6-Survivin1-120 mass. 
 
 
 
 
 
 
 
 
Table 6.2: Mass differences between paF-containing His6-Survivin1-120 mutant proteins 
with arginine, rather than paF, incorporated at the amber stop codon. 
 
 
 
 
 
 
 
 
 
Mutant Mass (Da)
paFNtermR, paFCtermR 16134.20
paF10R, paF67R 15947.98
paF93R, paF101R 15987.01
paF99R 15870.93
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A mass difference of 32.0 Daltons is detectable using LTQ FT mass 
spectrometry, and could be used to determine if arginine, instead of paF, was 
incorporated at the amber stop codon.  The aforementioned approaches may address 
whether or not paF or arginine had been incorporated into the Survivin protein, in a site-
specific manner. 
 
Strategies to Confirm Copper-free Click Chemistry Reaction Success with 
Azide-Containing Survivin Protein 
FPLC and fluorescence data suggested that the copper-free click chemistry 
reaction between N-terminal paF-containing His6-Survivin1-120 and DBCO488 was 
successful.  To corroborate those data and to confirm that paF-containing His6-
Survivin1-120 had been adducted with DBCO488, an aliquot of pure (Figure 3.12) 
uncleaved CtermpaF-DBCO488-Survivin1-120 was submitted for mass spectrometry 
analysis (MS Bioworks, Ann Arbor, MI).  Despite adequate sample purity, concentration, 
and preparation, satisfactory whole-protein mass spectrometry data were not obtained.  
Specifically, the MS Bioworks analyst had diluted the sample with 0.1% trifluoroacetic 
acid, which can suppress ionization [Balogh, 2009] and then indicated that the sample 
was of inadequate concentration and contained detergents and impurities, which was 
inconsistent with the sample preparation performed prior to shipment.  In addition, the 
MS Bioworks analyst indicated that the sample was allowed to thaw at room 
temperature for 30 minutes, exposed to UV illumination, prior to analysis.  These steps 
may have led to decomposition of the sample and/or photodestruction of the fluorophore 
prior to analysis.  Therefore, LTQ FT mass spectrometry could be repeated using a 
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different collaborator or resource.  The fluorescently-labeled construct would have a 
mass of 16818.26 Da, a difference of 840.26 Da from His6-Survivin1-120.  Site-specific 
incorporation could be confirmed using tryptic digest followed by LTQ FT mass 
spectrometry.  
Taken together, although the current findings indicate that Survivin gene 
sequences for insertion of paF were correct, Survivin protein was overexpressed, 
arginine incorporation was minimal, and fluorescence data suggest that a protein had 
been fluorescently labeled, the objectives of chapter 3, to site-specifically fluorescently 
label the Survivin protein, remain unconfirmed.  Ascertaining that these objectives had 
been met would enable steady-state fluorescence intensity measurements of Survivin 
with histone-3 and fluorescence lifetime determinations of Survivin with histone-3 with 
more confidence than with the existing set of data and interpretations. 
 
6.3 General Considerations for the Utility of Fluorescence-based Approaches to 
Evaluate Survivin Protein-Protein Interactions 
 As was described in chapter 3, fluorescence-based approaches including steady-
state intensity, FRET, and fluorescence lifetime may be used to evaluate protein-protein 
interactions.  Depending on the objective of the experiment, it may or may not be 
necessary to site-specifically fluorescently-label the protein of interest.  When it is 
important to know the exact location of the fluorophore, site-specific labeling techniques 
such as genetic encoding or site-directed mutagenesis with unnatural amino acid 
incorporation followed by click chemistry may be utilized.  Because the protein of 
interest is labeled with a fluorophore, considerations should be made in the placement 
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and size of the fluorophore, as well as of the excitation and emission maxima of 
endogenous fluorophores in the protein of interest, the fluorophore, and of any other 
fluorophores that may be present in the experimental assay buffer or biological matrix.  
If a relatively large fluorophore such as green fluorescent protein (GFP) is used, this 
may alter the conformation of the protein to which it is fused, which may prevent proper 
association of the target protein with its binding partner(s).   
Additional considerations when selecting the fluorophore include fluorophore 
solubility, quantum yield, extinction coefficient, Stokes shift, factors that may affect its 
fluorescence lifetime (protonation state), and spectral overlap with potential donors and 
acceptors. 
 
6.4 Label-Free Approaches to Evaluate Protein-Protein Interactions 
Bio-Layer Interferometry 
 An alternative to fluorescence-based approaches to monitor protein-protein 
interactions is Bio-Layer Interferometry (BLI). This method relies on changes that occur 
in the interference pattern of white light upon protein binding.  Briefly, target protein is 
immobilized on a biosensor tip; molecules that bind the target protein will cause a 
change in the interference pattern.  These changes can be monitored as a wavelength 
shift.  Some advantages of BLI are that measurements and output are in delivered real-
time.  Although labeling of the protein of interest is not a prerequisite for BLI 
experiments, a variety of different biosensor tips are available including nickel-NTA tips 
for analyzing His-tagged proteins.  Each analysis uses a 4 microliter volume and 
because the platform rotates at 2000 rpm, the method is insensitive to changes in flow 
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rate and changes in the refractive index of the sample buffer.  In addition, the sample 
may not be irreversibly damaged during analysis.  A variety of analyses may be 
completed including identification of protein partner binding, identification of candidate 
protein-protein interaction inhibitors, and protein partner binding affinity.  Given the 
difficulty obtaining sufficient quantities of thrombin-cleaved Survivin protein and the 
advantages with BLI, it may be worthwhile to pursue BLI for the high-throughput 
screening of candidate Survivin-histone-3 protein-protein interaction inhibitors. 
Limitations of BLI include that the protein of interest may bind the tip in a 
conformation that is not physiologically relevant.  This could be assessed using a variety 
of different BLI tips and considering the use of a labeled protein target (such as a His6- 
tag and nickel-NTA BLI tip), positioning the label such that it would not hamper the 
target protein’s folding and conformation, and altering the concentrations of target 
protein used in each experiment.  In addition, non-specific binding of proteins to the BLI 
tip is also possible.  To evaluate the specificity of protein target binding to the tip, 
antibodies against the protein target may be applied, the specificity of which should 
already be known (evaluated by western blotting, for example): binding of the antibody 
to the protein on the BLI tip will elicit a shift in the interference pattern.  If the antibody 
does not bind the tip, this may suggest that the protein of interest is not bound to the BLI 
tip.  An alternative interpretation is that the antibody does not recognize the protein in 
the conformation that binds the tip, either because the target protein is improperly folded 
or the interface to which the antibody binds is obscured by a tag or by binding to the BLI 
tip.  Regarding the experimental conditions, the amount of salt and/or detergent should 
be considered in the buffer.  For protein-protein interactions that are governed by 
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electrostatics, such as that between Survivin, borealin, and inner centromere protein 
(INCENP) [Jeyaprakash, et al., 2007], salt content similar to that found in the 
intracellular mileu, ~150 mM [Lodish, 1999], would be ideal.  Excess salt within the 
buffer would likely interfere with Survivin binding borealin and INCENP. 
 
6.5 Analyses to Evaluate Clickable Chelator Synthesis 
Chapter 4 described efforts to synthesize a small molecule clickable lanthanide 
chelator.  Fluorescence-based and HPLC approaches yielded preliminary data that 
suggested that synthesis was successful, however, additional analyses are warranted.  
Specifically, small-molecule mass spectrometry data yielded peaks that corresponded 
to the clickable chelator as well as to the product of the copper-free click chemistry 
reaction between the clickable chelator and paF, the clicked chelator, however, the data 
contained many unassigned fragment peaks as well as substantial peaks from the 
matrix blanks, which precluded unequivocal assignment of the matrix and experimental 
sample peaks.  In order to obtain more reliable small-molecule mass spectrometry data, 
several strategies could be pursued, as described below. 
The current HPLC separation method utilized trifluoroacetic acid, which can 
suppress ionization [Balogh, 2009].  Potentially, replacement of trifluoroacetic acid with 
formic acid in the HPLC separation may improve mass spectrometry detection of the 
clickable chelator.  In addition, using the C18 stationary phase and the existing method 
(chapter 2), the clicked chelator exhibited a retention time of approximately 6 minutes 
and the clickable chelator exhibited a retention time of approximately 7 minutes.  
Increasing the difference between these two species’ retention times could improve 
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collection of single fractions containing each species; fractions submitted for mass 
spectrometry would then contain single species.  Strategies to increase the difference 
between these two species’ retention times may include varying the gradient, using a 
stepwise gradient, and/or altering the composition of the mobile phases used for 
separation.  If satisfactory separation is not achieved using the C18 stationary phase, it 
may be possible to utilize a different stationary phase such as phenyl (Ascentis, Sigma). 
In addition to modifications in the HPLC separation and fraction collection 
techniques, alternatives may be pursued in the choice of small-molecule mass 
spectrometry used. Compared to matrix-assisted laser desorption/ionization (MALDI), 
electrospray ionization (ESI) is more sensitive for studying molecules ~1 kD and 
smaller.  Therefore, it may be beneficial to analyze the submitted fractions and samples 
by ESI. 
An additional piece of information that would improve peak assignment of the 
clickable chelator is the mass spectra of DTPA and metallated DTPA.  Using MALDI, 
terbium-metallated DTPA yielded convoluted mass spectrometry data, with multiple 
peaks present and uncertainty regarding whether or not terbium remained chelated 
during analysis.  ESI mass spectrometry analysis of DTPA with and without terbium 
may yield improved mass spectrometry data.  In addition, mass spectrometry data 
obtained on DTPA metallated with different lanthanides may yield fragmentation 
patterns that provide insight on whether or not DTPA remains metallated during 
analysis.  The peak assignments that would result from these experiments may help 
peak assignments from analysis of the clickable chelator.  Possible outcomes of mass 
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spectrometry analysis of DTPA:lanthanide are based on the protonation state of DTPA 
and the masses of the chelated lanthanides:  
Unmetallated DTPA has a single pKa, at 1.8 [Moeller and Thompson, 1962].  
DTPA chelates lanthanide at a 1:1 molar stoichiometry [Moeller and Thompson, 1962] 
and metallation of DTPA with lanthanide yields 5 distinct pKa, 1.80, 2.55, 4.33, 8.60, 
and 10.58 [Moeller and Thompson, 1962].  At a pH of 5.5, at which the metallation and 
syntheses were performed (chapter 4), metallated DTPA would fluctuate between two 
species, carrying -3 or -4 charge.  The mass of fully protonated DTPA is 393.35 Da, so 
the masses of DTPA-3 and DTPA-4 are 390.35 and 389.35 Da, respectively.  The mass 
of terbium is 158.93 Da.  Therefore, the mass of metallated DTPA would be 552.28 Da 
(Table 6.3).  If terbium becomes dissociated during analysis and DTPA accepts a 
proton, other combinations of masses may be possible, as indicated.  If mass 
spectrometry yields a peak at 549.28 Da, this may suggest that the DTPA:Tb complex is 
intact.  If the mass spectrometry yields peaks at 158.93 Da and 390.35 Da, this may 
suggest that the lanthanide became unbound during ionization.  The mass of europium 
is 151.96 Da, so metallation of DTPA-3 with europium would yield a mass of 542.31 Da.  
If mass spectrometry of europium-metallated DTPA yields peaks at 151.96 Da and 
390.35 Da, this would corroborate the conclusion with terbium-metallated DTPA that the 
lanthanide becomes unbound during analysis.  A fragmentation event within the DTPA 
molecule may also yield peaks of different masses depending on whether or not the 
lanthanide remains chelated during analysis.  These and other interpretations should be 
considered if additional mass spectrometry analyses are performed.  Ultimately, it will 
be important to fully utilize the available mass spectrometry opportunities to determine 
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whether or not the synthesis of the clickable chelator and clicked chelator were 
successful.  
In addition, NMR analyses to evaluate the structure of the clickable chelator in a 
paF-containing 15N-backbone-labeled Survivin1-120 protein may provide additional 
information on copper-free click chemistry reaction success between the clickable 
chelator and paF-containing Survivin1-120.   
Taken together, the objectives of the efforts described in chapter 4 aimed to 
synthesize, using a two-step, aqueous synthesis, a small-molecule lanthanide chelator 
amenable to copper-free click chemistry-mediated incorporation into the target protein.   
Although the fluorescence and HPLC data suggested that the small-molecule chelator 
was synthesized and that the copper-free click chemistry reaction between the clickable 
chelator and the small-molecule paF were successful, the small-molecule mass 
spectrometry data were inconclusive.  In addition, the clickable chelator has yet to be 
incorporated into a paF-containing Survivin1-120 protein and NMR experiments are 
remaining, therefore the objectives of the aims described in chapter 4 were unmet. 
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Table 6.3: Masses of uncharged and charged DTPA species, terbium, europium, and of 
different DTPA species metallated with terbium or europium. 
DTPA
Mass 
(Da)
Terbium 
Mass (Da)
Complex 
Mass (Da)
Europium 
Mass (Da)
Complex 
Mass (Da)
uncharged 393.35 158.93 552.28 151.96 545.31
DTPA
-1 392.35 158.93 551.28 151.96 544.31
DTPA
-2 391.35 158.93 550.28 151.96 543.31
DTPA
-3 390.35 158.93 549.28 151.96 542.31
DTPA
-4 389.35 158.93 548.28 151.96 541.31
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6.6 Considerations for the Utility of Lanthanide Chelation in NMR Structure 
Determination 
 Optimizing Lanthanide Chelator Insertion 
Chapter 3 describes the use of the unnatural amino acyl tRNA synthetase to 
facilitate site-specific incorporation of the unnatural amino acid paF.  Optimization of the 
Methanococcus jannaschii (Chapter 2) bacterium, which encodes the tRNA synthetase, 
to modify unnatural amino acid recognition and retrieval has already been demonstrated 
for over seventy unnatural amino acids [Wang, et al., 2006, Xie, et al., 2007, Brustad, et 
al., 2008, Lee and Schultz, 2008].  Therefore, it may be possible to optimize insertion of 
the clicked lanthanide chelator (clicked chelator) into the protein of interest.  First, the 
clicked chelator synthesis and purification is completed ex vivo.  Next, translation of the 
protein of interest is performed in an Escherichia coli culture in the presence of the M. 
jannaschii tRNA synthetase that retrieves the clicked chelator, with clicked chelator 
added to the incubation medium.  This yields a protein with site-specific incorporation of 
the lanthanide chelator.  Using this strategy negates the need to perform copper-free 
click chemistry on the protein of interest, minimizing the risk of non-specific 
incorporation of the chelator to the protein.  If the tRNA synthetase can differentially 
select one stereoisoform of the clicked chelator, an additional advantage could also be 
that only one stereoisomer of the clicked chelator is retrieved for incorporation into the 
growing polypeptide chain.  To determine whether or not the clicked chelator may cross 
the bacterial membrane, fluorescence analyses may be performed on lysed bacterium 
to ascertain the presence of the clicked chelator, which possesses fluorescence 
emission unique from that of the culture medium and bacterium. 
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One drawback to this proposed genetic incorporation of the clicked chelator, 
however, is that the clicked chelator is approximately 1 kD and contains an 
incompressible moiety in the DTPA chelation of terbium, so the ribosome peptidyl 
transferase center and amino acyl tRNA synthetase would need to be large enough to 
accommodate the clicked chelator.  The risk of this approach is that many antibiotics 
including erythromycin (733.93 g/mol), telithromycin (812.03 g/mol), clindamycin 
(504.96 g/mol), and chloramphenicol (323.13 g/mol) are small molecules that block 
nascent polypeptide translocation through the bacterial ribosomal peptidyl transferase 
center or block the exit tunnel of the 50S ribosomal subunit [Dunkle, et al., 2010].  Using 
ChemDraw, the clicked chelator structure was rendered using correct bond angles and 
lengths (Figure 4.1); the approximate length of the clicked chelator that extends 
perpendicularly from the polypeptide backbone is 13 Å.  The approximate length from 
the central nitrogen in the triazole moiety to the carboxylic acids chelating the terbium is 
24.5 Å.  The approximate circumference of the chelated terbium is 33.8 Å.  Because the 
chelator moiety of the 1 kD clicked chelator is incompressible, the clicked chelator may 
not traverse the peptidyl transferase center without inhibiting polypeptide synthesis.   
Another consideration for this proposed approach is that it is not yet known 
whether or not the tRNA synthetase active site could accommodate the 1 kD size of the 
clicked chelator.  Optimization of the tRNA synthetase using degenerate primers and 
efforts used to incorporate the over seventy unnatural amino acids already published 
[Wang, et al., 2006, Xie, et al., 2007, Brustad, et al., 2008, Lee and Schultz, 2008] may 
be applied to optimization of the tRNA synthetase to accommodate the large size of the 
clicked chelator, however 1 kD may be beyond the capacity of the synthetase to 
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simultaneously 1) recognize and recruit the clicked chelator while 2) retaining ATP-
mediated charging of the tRNA with the clicked chelator.  For these reasons, it may be 
prudent to consider incorporation of a smaller unnatural amino acid. 
It is appealing to consider truncating the clicked chelator to a smaller molecule 
that still retains the ability to 1) chelate lanthanide and 2) be incorporated site-
specifically into the protein backbone.  This may be accomplished by incorporating a 
portion of the clicked chelator as an unnatural amino acid.  In this context, the smallest 
possible unit may be DTPA:Tb with the central carboxylic acid modified to an amide 
bond; this would facilitate incorporation into the growing polypeptide chain as the amino 
acid side chain is the DTPA:Tb construct.  This amidated DTPA:Tb construct thus 
becomes an unnatural amino acid.  Subsequently, tRNA synthetase optimization is 
performed using degenerate primers, as has been previously done with other unnatural 
amino acids [reviewed in Liu and Schultz, 2010] to generate a tRNA that retrieves the 
amidated DTPA:Tb lanthanide chelator for ribosomal insertion into the growing 
polypeptide chain. 
Regarding the possibility of unnatural amino acid-mediated direct incorporation of 
the lanthanide chelator into the target protein during translation, our analyses indicate 
that the clickable chelator retains terbium fluorescence during purification, suggesting 
that terbium remains chelated during synthesis and purification.  It is not known, yet, if 
terbium would remain chelated during protein translation or if it would be toxic to the 
bacterial culture.  Analysis of the fluorescence of the protein after overexpression and 
purification would yield information about whether or not terbium remained chelated 
during translation.  In addition, fluorescence and mass spectrometry analyses of the 
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resulting protein could yield information about whether or not the chelator had been 
incorporated with and without terbium.  
These two strategies facilitate direct incorporation of a small-molecule lanthanide 
chelator into the protein of interest.  They also negate the need to perform copper-free 
click chemistry on the protein of interest. 
 
Optimizing Chelator Rigidity  
Regarding lanthanide chelation, for NMR-based analyses, it is critical for the 
chelator to rigidly chelate the lanthanide to orient pseudocontact chemical shifts.  One 
strategy to facilitate rigid chelation is that of “caged” lanthanide incorporation, as was 
demonstrated with a DTPA derivative and cysteine reactivity [Prudêncio, et al., 2004].  
This approach, however, does not address the issue of non-specific cysteine reactivity 
and the potential consequences of cysteine insertion or mutation on the target protein’s 
tertiary structure.  Therefore, it may be beneficial to consider other alternatives. 
One strategy to incorporate a rigid chelator is to synthesize a chelator that 
contains bonds with low degrees of rotation.  To date, such a molecule does not yet 
exist that can be site-specifically incorporated into the protein of interest.  To fully 
harness lanthanide chelation and the pseudocontact chemical shift perturbation for 
structure determination, incorporation of a rigid small molecule lanthanide chelator 
without perturbing protein backbone or secondary structure is necessary; these 
properties may be mutually exclusive. 
The aforementioned strategies describe optimization of lanthanide incorporation 
for NMR-based structural analyses.  Lanthanides may also be employed for 
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fluorescence-based analyses.  The potential utility of lanthanide chelation in high-
throughput rational screening may also be considered. 
 
6.7 Lanthanide Chelation for Fluorescence Polarization-based Rational Screening 
Chapter 5 described the utility of fluorescence polarization-based rational 
screening to identify promising therapeutic candidates.  Currently, peptide binding 
partners of the protein target may be commercially synthesized and may include 
fluorophores such as carboxyfluorescein.  An alternative approach would be to 
synthesize peptides containing the unnatural amino acid paF, then perform copper-free 
click chemistry to adduct the clickable chelator to the peptide.  This process would yield 
a peptide containing site-specific lanthanide incorporation, which could then be utilized 
in fluorescence polarization-based screening analyses.  An additional application would 
be NMR-based protein-protein interaction studies where the lanthanide-labeled peptide 
is titrated into the 15N-backbone-labeled protein of interest to evaluate consequences of 
titration of peptide on target protein structure; these complementary approaches, 
fluorescence polarization and NMR, would yield valuable information with streamlined 
effort because the same proteins could be evaluated in multiple approaches.  Candidate 
molecules identified using fluorescence polarization may be applied to the protein in 
NMR-based structural analyses.  These NMR analyses could provide structural 
information about candidate inhibitor binding to disrupt the protein-peptide interaction 
from the fluorescence polarization screen.   
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Limitations of Fluorescence Polarization to Identify Candidate Protein-
Peptide Interaction Inhibitors 
Although fluorescence polarization-based analyses can be utilized to identify 
candidate protein-peptide interaction inhibitors and offers many advantages to 
alternative approaches, the methodology is not without limitation.  In addition to 
correcting for false positives and negatives, which add additional samples and expense, 
it may be difficult to procure pure protein in a physiologically-relevant conformation, in 
concentrations amenable to optimal signal:noise ratio of the experiment.  In addition, 
although it may be possible to monitor fluorescence of endogenous amino acids such 
as tryptophan, tyrosine, or phenylalanine in the peptide binding partner, these amino 
acids are likely present in the protein target as well, thereby precluding use of these 
amino acids’ fluorescence properties in fluorescence polarization.  An alternative to 
endogenous fluorophores in fluorescence polarization is exogenous fluorophores such 
as carboxyfluorescein, which can be incorporated during synthesis of synthetic 
peptides.  Peptide synthesis with and without fluorophore labeling can be quite 
expensive, costing thousands of dollars for approximately 15-amino acid-long peptides.  
As with other techniques that require labels, insertion or incorporation of a fluorophore 
into the peptide sequence may interfere with binding of the peptide to the protein target, 
so it is important to consider the location of the fluorophore within the peptide during 
synthesis and the potential consequences of peptide binding the protein target. 
Finally, the objectives of the experiments described in chapter 5, to establish a 
fluorescence-polarization-based high-throughput screening assay of candidate Survivin-
histone-3 protein-protein inhibitors, were unmet.  Specifically, analyses described in 
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chapter 5 to determine fluorescently-labled histone-3 peptide dissociation constant, 
binding specificity, and effect of DMSO, temperature, and pH used His6-Survivin1-120, but 
it was determined that fluorescently-labeled histone-3 peptide bound His6-Survivin1-120 
non-specifically.  It will also be important to evaluate the incubation time of the assay.  
In order to establish the HTS platform, the experiments may be performed using 
thrombin-cleaved Survivin1-120. 
 
6.8 Summary and Conclusions 
Fluorescence-based approaches including steady-state intensity, FRET, and 
fluorescence lifetime analyses to evaluate protein-protein interactions are useful 
indicators of local fluorophore environment.  An appreciation for each approach’s 
limitations and advantages is imperative for proper data interpretation; used correctly, 
fluorescent labeling of a protein of interest can be a useful technology that facilitates 
study of protein-protein interactions.  To this end, fluorescent labeling of the Survivin 
protein, an important anti-cancer target, was achieved coupling site-directed 
mutagenesis, unnatural amino acid insertion, and copper-free click chemistry.  These 
low-resolution fluorescence-based approaches may provide information about the 
fluorophore local environment that may complement structure determination methods 
such as x-ray crystallography and nuclear magnetic resonance spectroscopy.   
Expanding the utility of x-ray crystallography and NMR using lanthanide chelation 
is promising.  Current small-molecule lanthanide chelators originate from multi-step- 
organic syntheses that yield cysteine-reactive and other types of chelators that may or 
may not be site-specifically incorporated into the protein of interest.  Described in 
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chapter 4 is the 2-step aqueous synthesis of a small-molecule lanthanide chelator 
amenable to copper-free click chemistry-mediated site-specific incorporation into the 
Survivin protein.  Described within chapter 5 is a fluorescence polarization-based 
platform amenable to high-throughput screening of candidate protein-peptide interaction 
inhibitors. 
 The efforts of the experiments described in chapter 3 aimed to site-specifically 
label the Survivin protein with a fluorescent tag using copper-free click chemistry.  
Outstanding analyses include confirming synthesis of the paF-containing Survivin 
protein and the fluorescently-labeled Survivin protein using mass spectrometry.  Also 
outstanding are experiments determining the steady-state fluorescence intensity and 
fluorescence lifetimes of fluorescently-labeled Survivin with its binding partners.  The 
efforts of the experiments described in chapter 4 aimed to synthesize, using two steps 
and aqueous conditions, a small-molecule lanthanide chelator amenable to site-specific 
copper-free click chemistry-mediated incorporation into the Survivin protein.  The goals 
of the aim were unmet as the small-molecule mass spectrometry experiments need to 
be repeated to confirm synthesis of the chelator.  Additional outstanding experiments 
include clicking the chelator into a paF-containing Survivin protein and performing NMR 
experiments on Survivin with its binding partners.  Finally, the goals of the experiments 
described in chapter 5 aimed to establish a high-throughput fluorescence polarization 
screening assay to identify putative inhibitors of the Survivin-histone-3 protein-protein 
interaction.  The goals were unmet as the outstanding experiments include establishing 
fluorescence polarization assay robustness using thrombin-cleaved Survivin1-120 then 
performing the screening experiments. 
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Collectively, the efforts described herein were undertaken to springboard 
improved structure-aided drug design and rapid identification of therapeutic candidate 
molecules.  Although the protein target described within this dissertation, Survivin, is a 
promising anti-cancer target, the efforts to evaluate protein-protein interactions using 
these approaches could be applied to many different protein targets.  Targeting protein-
protein interactions is a promising strategy to expand therapeutic opportunities against 
proteins that are non-enzymatic and involved in many different intracellular pathways.  
Therefore, the efforts described herein have potential to expand therapeutic targeting 
beyond those of conventional approaches, offering hope for treatment of many human 
and animal diseases. 
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